Page last updated: 2024-08-24

sertraline and Depression, Involutional

sertraline has been researched along with Depression, Involutional in 479 studies

Research

Studies (479)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	9 (1.88)	18.2507
2000's	193 (40.29)	29.6817
2010's	211 (44.05)	24.3611
2020's	66 (13.78)	2.80

Authors

Authors	Studies
Chin Fatt, C; Cooper, C; Fava, M; Jha, MK; Kurian, B; McGrath, PJ; Mellema, C; Montillo, AA; Nguyen, KP; Phillips, ML; Treacher, A; Trivedi, MH; Weissman, M	1
Brown, K; Cogan, ES; DeBattista, C; Dunlop, BW; Forester, BP; Greden, JF; Hain, DT; Jablonski, MR; Law, RA; Lewis, DJ; Macaluso, M; Parikh, SV; Rothschild, AJ; Shelton, RC; Thase, ME	1
Lane, HY; Lin, CH; Wang, SH	1
Akhondzadeh, S; Khadivi, A; Momtazmaneh, S; Samsami, FS; Shalbafan, M; Shirazi, E; Shobeiri, P	1
Gulfishan, S; Gupta, R; Halder, S; Kar, R; Srivastava, S	1
de Meulenaere, J; De Proost, A	1
Dahlmanns, JK; Dahlmanns, M; Groemer, TW; Kornhuber, J; Trepl, J	1
Amici, E; De Filippis, S; Di Giovanni, A; Giovanetti, V; Kotzalidis, GD; Lombardozzi, G; Matrone, M; Perrini, F; Trovini, G	1
Cipelli, R; Dell'Osso, B; Di Nicola, M; Martinotti, G; Peduto, I; Pugliese, AC; Signorelli, MS; Ventriglio, A	1
Carmody, T; Chase, HW; Cooper, CM; Deckersbach, T; Fava, M; Kaiser, RH; McGrath, PJ; McInnis, MG; Oquendo, MA; Parsey, RV; Phillips, ML; Pizzagalli, DA; Trivedi, MH; Weissman, M	1
Avram, MJ; Caritis, SN; Ciolino, JD; Clark, S; Costantine, MM; George, AL; Mesches, GA; Rasmussen-Torvik, LJ; Stika, CS; Venkataramanan, R; West, HA; Wisner, KL; Zumpf, K	1
Cadwallader, A; Coskuner, J; Hasey, G; Oakley, T; Ravan, M	1
Coimbra, BM; D'Elia, ATD; Juruena, MF; Mello, AF; Mello, MF	1
Chin Fatt, C; Jha, MK; Mayes, TL; Minhajuddin, A; Trivedi, MH	1
Beliveau, V; Dam, VH; Fisher, PM; Frokjaer, VG; Ganz, M; Hedeboe, E; Jørgensen, MB; Knudsen, GM	1
Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Okuya, M; Sakuma, K	1
Mimura, M; Sakurai, H; Suzuki, T; Takeuchi, H; Tsujii, T; Uchida, H	1
Goodwin, GM; Joas, E; Jonsson, L; Landén, M; Pålsson, E; Smedler, E; Viktorin, A	1
Chin Fatt, CR; Jha, MK; Mayes, T; Minhajuddin, A; Rush, AJ; Trivedi, MH	1
Amada, N; Futamura, T; Hirose, T; Kakumoto, Y; Kikuchi, T; Maeda, K; Suzuki, M	1
Carlisle, N; Chidharom, M; Etkin, A; Fonzo, GA; Tong, X; Xie, H; Zhang, Y; Zhao, K	1
Hong, S; Kong, YT; Kuang, L; Liao, J; Ran, LY; Xiang, JJ; Zeng, Q; Zhang, CY	1
A Basti, F; Akhondzadeh, S; Arab Bafrani, M; Asadigandomani, H; Kafi, F; Shamabadi, A	1
Alexopoulos, GS; Bingham, KS; Butters, MA; Calarco, N; Dickie, EW; Flint, AJ; Marino, P; Meyers, BS; Mulsant, BH; Neufeld, NH; Rothschild, AJ; Voineskos, AN; Whyte, EM	1
Cao, Q; Rao, Y; Yang, R; Zhao, J	1
Ilic, N; Jankovic, SM; Milovanovic, J; Nikolic, VN; Popovic, D; Stoiljkovic, M; Vujovic, M	1
Alexopoulos, GS; Bingham, KS; Flint, AJ; Hoptman, MJ; Marino, P; Meyers, BS; Mulsant, BH; Neufeld, NH; Oliver, LD; Rothschild, AJ; Tani, H; Voineskos, AN; Whyte, EM	1
Hedayati, A; Hosseini, FA; Shaygan, M; Shemiran, M	1
Brand, S; Brühl, AB; Davarinejad, O; Shahmoradi, N	1
Lei, F; Sun, Y; Zheng, Z; Zou, K	1
Alexopoulos, GS; Banerjee, S; Flint, AJ; Marino, P; Meyers, BS; Mulsant, BH; Pollari, CD; Rothschild, AJ; Rudorfer, MV; Voineskos, AN; Whyte, EM; Wu, Y	1
Arns, M; Boutros, NN; Fallahpour, K; van der Vinne, N; van Putten, MJAM; Vollebregt, MA	1
Adams, P; Almeida, JR; Aslam, H; Carmody, T; Chase, HW; Cooper, C; Deckersbach, T; Fava, M; Fournier, JC; Greenberg, T; Kurian, B; McGrath, PJ; McInnis, MG; Oquendo, MA; Parsey, R; Peltier, S; Phillips, ML; Stiffler, R; Toups, MS; Trivedi, M; Weissman, M	1
Adams, P; Carmody, T; Chin Fatt, CR; Cooper, CM; Etkin, A; Fava, M; Fonzo, G; Grannemann, B; Greer, TL; Jha, MK; Kurian, B; McGrath, PJ; McInnis, M; Parsey, RV; Phillips, ML; South, C; Trivedi, MH; Weissman, M	1
Goldstein-Piekarski, AN; Korgaonkar, MS; Tozzi, L; Williams, LM	1
Ahmadpanah, M; Akhondzadeh, S; Brand, S; Ghaleiha, A; Ramezanshams, F; Sadeghi Bahmani, D	1
Fornito, A; Goldstein-Piekarski, AN; Korgaonkar, MS; Williams, LM	1
Artun, NY; Baskak, B; Oz, MD; Ozdemir, H; Ozel, TK; Ozguven, HD; Suzen, HS; Uckun, Z	1
Arns, M; van der Vinne, N; van Putten, MJAM; Vollebregt, MA	1
Andrade, C; Nachane, H; Sasikumaran, A; Sharma, N	1
Carmody, T; Gregg, LP; Hedayati, SS; Le, D; Toto, RD; Trivedi, MH	1
Al-Dujaili, AH; Al-Hakeim, HK; Maes, M; Twayej, AJ	2
Chin-Fatt, C; Cooper, C; Deckersbach, T; Etkin, A; Fava, M; Fonzo, GA; Jha, MK; Pizzagalli, DA; Rolle, CE; Toll, R; Trivedi, MH; Trombello, JM; Weissman, MM; Wu, W	1
Adams, P; Arns, M; Caudle, TL; Chin-Fatt, C; Cooper, C; Cornelssen, CA; Deckersbach, T; Etkin, A; Fava, M; Fonzo, GA; Jha, MK; Jiang, J; Krepel, N; Lucas, MV; McGrath, PJ; Monuszko, K; Pizzagalli, DA; Rolle, CE; Sarhadi, K; Toll, RT; Trivedi, HM; Trivedi, MH; Trombello, JM; Weissman, MM; Wright, R; Wu, W; Zhang, Y	1
Gao, L; Liao, Y; Wang, J; Wu, C	1
Liao, XM; Si, TM; Su, YA; Wang, Y; Yu, X	1
Alexopoulos, GS; Dickie, EW; Flint, AJ; Hoptman, MJ; Lerch, JP; Meyers, BS; Mulsant, BH; Neufeld, NH; Rothschild, AJ; Voineskos, AN; Whyte, EM	1
Akhondzadeh, S; Ali Noorbala, A; Aqamolaei, A; Borhannejad, F; Hosein Mortazavi, S; Kamalzadeh, L; Mortezaei, A; Naderi, S; Namazi-Shabestari, A; Saeb, A; Sahebolzamani, E; Shalbafan, M; Shariati, B	1
Choi, WJ; Kim, B; Kim, S; Kim, WJ; Park, JY; Park, S; Roh, D; Son, SJ	1
Adams, P; Almeida, J; Ang, YS; Bruder, G; Carmody, T; Chase, HW; Chin Fatt, CR; Cooper, CM; Deckersbach, T; Deldin, P; Fava, M; Kaiser, R; McGrath, P; McInnis, MG; Oquendo, MA; Parsey, R; Phillips, ML; Pizzagalli, DA; Trivedi, MH; Webb, CA; Weissman, M	1
Basu, S; Dass, N; Irvin, J; Keller, AS; Ng, A; Rajpurkar, P; Taylor, Z; Vale, V; Williams, LM; Yang, J	1
Chin Fatt, C; Jha, MK; Minhajuddin, A; Trivedi, MH	1
Akechi, T; Debray, TPA; Efthimiou, O; Furukawa, TA; Kato, T; Seo, M; Yamada, M	1
Gregg, LP; Hedayati, SS	1
Hsu, LM; Kao, HW; Lane, TJ; Lin, CP; Lin, CY; Wu, CW; Yeh, CB	1
Jain, SB; Jha, MK; Rush, AJ; South, C; Trivedi, MH	1
Babyak, MA; Blumenthal, JA; Craighead, WE; Davidson, J; Doraiswamy, PM; Hinderliter, A; Hoffman, B; Sherwood, A	1
Aslan, S; Chin Fatt, CR; Cooper, C; Etkin, A; Fava, M; Grannemann, B; Greer, TL; Jha, MK; Kurian, B; McGrath, PJ; Parsey, RV; Phillips, ML; Trivedi, MH; Weissman, M	1
Baier, AL; Feeny, NC; Klein, AB; Kline, AC; Zoellner, LA	1
Duax, JM; Feeny, NC; Jaeger, J; Marks, EH; Walker, RSW; Zoellner, LA	1
Alschuler, DM; Ang, YS; Bruder, GE; Carmody, T; Cooper, CM; Cusin, C; Deldin, P; Fava, M; Keilp, JG; McGrath, PJ; McInnis, MG; Oquendo, MA; Parsey, R; Pechtel, P; Pizzagalli, DA; Rutherford, A; Trivedi, MH; Webb, CA; Weissman, M	1
Chin Fatt, CR; Cooper, CM; Fava, M; Jha, MK; McInnis, M; Minhajuddin, A; Rush, AJ; Trivedi, MH; Trombello, JM; Weissman, M	1
Bigos, KL; Brasic, J; Dannals, RF; Gould, NF; Hall, AW; Holt, DP; Joo, JH; Kraut, M; Kuwabara, H; Mathews, WB; Nandi, A; Nassery, N; Savonenko, A; Smith, GS; Workman, CI	1
Frankle, WG; Lequesne, E; Rohs, A; Zhang, E	1
Akhondzadeh, S; Farajollahi-Moghadam, M; Ghazizadeh Hasemi, M; Sanatian, Z; Sanjari-Moghaddam, H; Talaei, A	1
Badcock, PB; Bailey, AP; Cox, GR; Hetrick, SE; McKenzie, JE; Meader, N; Merry, SN; Moller, CI; Sharma, V	1
Imperato, JS; Jin, YO; Li, JZ; Pappadopulos, EA; Si, T; Wang, G; Yan, L; Yang, L; Yu, W; Zou, KH	1
Braund, TA; Gordon, E; Harris, AWF; Palmer, DM; Rush, AJ; Tillman, G	1
Bahramali, E; Firouzabadi, N; Raeesi, R; Yavarian, I; Zomorrodian, K	1
Çetin, B; Ergelen, M	1
Bundrick, JB; Feely, MA; Litin, SC	1
Grabe, HJ; Janowitz, D; Schomerus, G; Speerforck, S	1
Bartova, L; Dold, M; Kasper, S; Rupprecht, R	1
Aparicio, LM; Benseñor, I; Borrione, L; Brunoni, AR; Fraguas, R; Kemp, AH; Lotufo, PA; Sampaio-Junior, B	1
Carmody, T; Gregg, LP; Hedayati, SS; Jain, N; Rush, AJ; Toto, RD; Toups, M; Trivedi, MH	1
Broadhouse, K; Gordon, E; Grieve, SM; Koslow, S; Maller, JJ; Rush, AJ	1
Aikoye, SA; Bradley, R; Khalid, Z; Noveloso, B; Osuagwu, FC; Shah, B	1
Amore, M; Cabassi, A; Ekkekakis, P; Ermini, G; Latessa, PM; Menchetti, M; Murri, MB; Neri, M; Nerozzi, E; Neviani, F; Squatrito, S; Tedeschi, S; Toni, G; Trevisani, F; Zanetidou, S; Zocchi, D	1
Banach, E; Dmitrzak-Węglarz, M; Leszczyńska-Rodziewicz, A; Pawlak, J; Szczepankiewicz, A; Twarowska-Hauser, J; Zaremba, D	1
Adams, P; Bruder, G; Carmody, T; Cooper, C; Deldin, P; Dillon, DG; Fava, M; Goer, F; Kayser, J; McGrath, P; McInnis, MG; Oquendo, MA; Parsey, R; Pizzagalli, DA; Tenke, CE; Trivedi, MH; Trombello, J; Webb, CA; Weissman, M	1
Kamijima, K; Kimura, M; Kitayama, Y; Kuwahara, K; Tadori, Y	1
Alexopoulos, GS; Artis, AS; Banerjee, S; Bingham, KS; Flint, AJ; Meyers, BS; Mulsant, BH; Rothschild, AJ; Whyte, EM	1
Adams, P; Bruder, G; Cohen, ZD; Cooper, C; Deldin, P; DeRubeis, RJ; Dillon, DG; Fava, M; Fournier, JC; Goer, F; Huys, Q; Jha, M; Kurian, BT; McGrath, PJ; McInnis, MG; Oquendo, MA; Parsey, R; Pizzagalli, DA; Trivedi, MH; Trombello, JM; Webb, CA; Weissman, M	1
Ballesteros, J; Cordero-Jiménez, JR; Espinosa-Rodríguez, NB; Lauria-Horner, B; Mendoza-Rodríguez, Y; Robaina-García, M; Sotolongo-Garcia, Y; Valle-Cabrera, R	1
Baskak, B; Demirbugen Oz, M; Devrimci Ozguven, H; Kizil Ozel, T; Ozdemir, H; Suzen, HS; Uckun, Z; Yuce-Artun, N	1
Gotlib, IH; Kircanski, K; Williams, LM	1
Firouzabadi, D; Firouzabadi, N; Kalani, K; Tehrani, ES; Zomorrodian, K	1
Pearlson, GD; Steffens, DC; Wang, L	1
Adams, P; Ali, A; Carmody, TJ; Grannemann, BD; Jha, MK; Killian, MO; Mayes, TL; McGrath, PJ; McInnis, M; Oquendo, MA; Parsey, RV; Rush, AJ; Trivedi, MH; Trombello, JM; Weissman, MM	1
Adams, P; Bruder, G; Carmody, T; Cooper, C; Deldin, P; Dillon, DG; Fava, M; Goer, F; Kayser, J; McGrath, P; McInnis, MG; Oquendo, MA; Parsey, R; Pizzagalli, DA; Rutherford, A; Trivedi, MH; Trombello, JM; Webb, CA; Weissman, M; Whitton, AE	1
Emam, H; Pearlson, GD; Steffens, DC; Wang, L	1
Holck, A; Lindqvist, D; Mellon, SH; Nelson, JC; Reus, VI; Westrin, Å; Wolkowitz, OM	1
Aitchison, KJ; Binder, EB; Carrillo-Roa, T; Cattaneo, A; DeModena, A; Henigsberg, N; Kelsoe, JR; Leckband, SG; Liu, JJ; McCarthy, M; Mors, O; Ren, H; Rietschel, M; Shekhtman, T; Wei, YB	1
Hirano, J; Hotta, S; Mimura, M; Tabuchi, H; Takei, Y; Yamagata, B; Yamanaka, K	1
Braund, TA; Harris, AWF; Palmer, DM; Williams, LM	1
Bajbouj, M; Cooper, K; Daly, EJ; Drevets, WC; Hough, D; Lane, R; Lim, P; Manji, H; Mazzucco, C; Molero, P; Popova, V; Shelton, RC; Singh, JB; Thase, ME; Trivedi, M; Vieta, E	1
Cooper, C; DeLorenzo, C; Fava, M; Huang, C; Kurian, B; LaBella, A; McGrath, P; McInnis, M; Oquendo, MA; Parsey, RV; Pillai, RLI; Pizzagalli, DA; Trivedi, M; Weissman, M; Yang, J; Zhang, M	1
Carney, RM; Freedland, KE; Harris, WS; Rich, MW; Rubin, EH; Steinmeyer, BC	2
Eriksson, E; Hieronymus, F; Lisinski, A; Nilsson, S	1
Black, KJ; Carter, J; Freedland, KE; Gilliam, FG; Lustman, PJ; Sheline, YI; Tsai, WY	1
Corruble, E; Demyttenaere, K; Hale, A; Kasper, S; Picarel-Blanchot, F; Quera-Salva, MA	1
Duval, F; Flabeau, O; Razafimahefa, J; Spampinato, U; Tison, F	1
Barch, DM; D'Angelo, G; Disabato, BM; Doraiswamy, PM; Hranilovich, J; Krishnan, RR; MacFall, JR; Morris, C; Pieper, C; Sheline, YI; Steffens, DC; Taylor, WD; Toffanin, T; Welsh-Bohmer, KA; Wilkins, C	1
Hochhegger, B; Irion, KL; Marchiori, E; Muly, S	1
Sheline, Y	1
Blumberger, DM; Flint, AJ; Kanellopoulos, D; Meyers, BS; Mulsant, BH; Rothschild, AJ; Whyte, EM	1
Benseñor, IM; Brunoni, AR; Brunoni, D; Coprerski, B; Cordeiro, Q; Fregni, F; Goulart, AC; Kemp, AH; Lotufo, PA; Perez, AB; Shiozawa, P; Valiengo, LC	1
Benseñor, IM; Boggio, PS; Brunoni, AR; de Oliveira, JF; Fregni, F; Goulart, AC; Lotufo, PA; Valiengo, L; Zanao, TA	1
Flint, AJ; Iaboni, A; Meyers, BS; Mulsant, BH; Rothschild, AJ; Whyte, EM	1
Kripalani, M; Suleman, M	1
Benseñor, IM; Boggio, PS; Brunoni, AR; Dantas, EM; Fregni, F; Goulart, AC; Kemp, AH; Lotufo, PA; Mill, JG; Nunes, MA	1
D'Angelo, GM; Disabato, BM; Doraiswamy, PM; Hranilovich, J; Morris, C; Sheline, YI; Wu, N; Zhou, G	1
Arasteh, M; Arntz, A; Huibers, MJ; Moradveisi, L; Renner, F	3
Drevets, WC; Fromm, SJ; Furey, ML; Öhman, A; Victor, TA	2
Hajak, G; Kasper, S	1
Etkin, A; Gordon, E; Grieve, SM; Harris, A; Korgaonkar, MS; Koslow, SH; Nemeroff, CB; Schatzberg, AF; Williams, LM; Wisniewski, S	1
Bogdanov, MB; Boyle, SH; Churchill, E; Delnomdedieu, M; Fiehn, O; Kaddurah-Daouk, R; Krishnan, RR; Matson, S; Matson, W; Pickering, E; Rush, JA; Sharma, S; Zhu, H	1
Albus, C; Hermanns, N; Herpertz, S; Hiemke, C; Hiller, W; Kronfeld, K; Kruse, J; Kulzer, B; Müller, MJ; Petrak, F; Ruckes, C	1
Gibiino, S; Marsano, A; Serretti, A	1
Benseñor, IM; Brunoni, AR; Fregni, F; Lotufo, PA; Schestatsky, P	1
Park, YM	1
Devanand, DP; Fitzsimons, L; Miyazaki, M; Pelton, GH; Reinlieb, ME; Roose, SP; Rutherford, BR; Sackeim, HA; Sneed, JR; Turret, N	1
Barber, JP; Barrett, MS; Dinger, U; McCarthy, KS; Zilcha-Mano, S	1
Barton, BA; Deligiannidis, KM; Flint, AJ; Kroll-Desrosiers, AR; Meyers, BS; Mulsant, BH; Rothschild, AJ; Whyte, EM	1
Grobler, AC; Matthews, G; Molenberghs, G	1
Brunoni, AR; Cordeiro, Q; Fregni, F; Shiozawa, P	1
Montgomery, SA; Reines, EH; Sanchez, C	1
Bech, P; Flint, AJ; Meyers, BS; Mulsant, BH; Rothschild, AJ; Ulbricht, CM; Whyte, EM; Østergaard, SD	1
Blumenthal, JA; Carney, RM; Combs, K; Craighead, WE; Freedland, K; Hoffman, B; Sherwood, A; Smith, PJ	1
Ishii, M; Kiuchi, Y; Kudo, I; Nakamura, S; Nishioka, G; Oyamada, H; Yashima, H	1
Jain, S	1
Davies, SJ; Flint, AJ; Meyers, BS; Mulsant, BH; Rothschild, AJ; Whyte, EM	1
Benseñor, IM; Brunoni, AR; Gattaz, WF; Lotufo, PA; Machado-Vieira, R; Nitsche, MA; Teixeira, AL; Valiengo, L; Vanderhasselt, MA; Vieira, EL; Zarate, CA	1
Gao, Y; Li, S; Liu, H; Ma, M; Wu, X; Yang, J; Yang, R; Zhang, H	1
Abdollahian, E; Azarpazhooh, A; Haghighi, MB; Mokhber, N; Saghebi, A; Samadi, R; Soltanifar, A	1
Aijaz, A; Ambareen, U	1
Benseñor, IM; Brunoni, AR; Gattaz, WF; Lotufo, PA; Machado-Vieira, R; Teixeira, AL; Valiengo, L; Vieira, EL; Zarate, CA	1
Brignone, M; Ereshefsky, L; Francois, C; Lançon, C; Llorca, PM; Rive, B; Salah, S	1
Allen, JJ; Fort, C; Lane, RD; Smith, R; Thayer, JF	1
Morrison, J; Schwartz, TL	1
Hassanpour Moghadam, M; Mohajeri, SA; Sajadi Tabassi, SA; Talaei, A	1
DeBattista, C; Keller, J; Kocsis, JH; Lazzeroni, LC; Murphy, GM; Ray, A; Ryan, HS; Sarginson, JE; Schatzberg, AF; Tennakoon, L; Trivedi, MH	1
IsHak, WW; Karamians, R; Peselow, ED; Pizano, D; Tobia, G	1
David, D; Iftene, F; Predescu, E; Stefan, S	1
Etkin, A; Patenaude, B; Rekshan, W; Rush, AJ; Schatzberg, AF; Song, YJ; Usherwood, T; Williams, LM	1
Arnow, BA; Boyce, PM; Day, CV; DeBattista, C; Etkin, A; Harris, AW; John Rush, A; Rekshan, W; Schatzberg, AF; Williams, LM	1
Demyttenaere, K; Dunbar, G; Eriksson, H; Hosford, D; Möller, HJ; Olausson, B; Szamosi, J; Tummala, R; Wilson, E	1
Fernández Ferreiro, A; González Barcia, M; Rodríguez Méndez, ML; Suárez Artime, P	1
Albus, C; Hermanns, N; Herpertz, S; Hiemke, C; Hiller, W; Kronfeld, K; Kruse, J; Kulzer, B; Müller, MJ; Petrak, F; Ruckes, C; Zahn, D	1
Dueñas, H; Haro, JM; Hong, J; Moneta, MV; Montgomery, W; Novick, D; Peng, X	1
Arnow, BA; Blasey, C; Etkin, A; Kulkarni, J; Luther, JF; Palmer, DM; Rekshan, W; Rush, AJ; Schatzberg, AF; Williams, LM	1
DeBattista, C; Etkin, A; Lazzeroni, LC; Murphy, GM; Schatzberg, AF; Williams, LM	1
Amsterdam, JD; Li, QS; Mao, JJ; Rockwell, K; Soeller, I; Xie, SX; Zee, J	1
Alao, A; Lewkowicz, C	1
Bagayogo, IP; Kaufman, KR; Schineller, TM; Schneider, JA; Tobia, A	1
Etkin, A; Grieve, SM; Gyurak, A; Korgaonkar, MS; Patenaude, B; Williams, LM	1
Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N	1
Arns, M; DeBattista, C; deBeuss, R; Etkin, A; Fitzgerald, PB; Gordon, E; Harris, A; Hegerl, U; Palmer, DM; Williams, LM	1
del Río-Casanova, L; Díaz-Llenderrozas, F; Portela, B	1
Bies, RR; Davies, SJ; Flint, AJ; Kirshner, MM; Meyers, BS; Mulsant, BH; Pollock, BG; Rothschild, AJ; Sorisio, D; Whyte, EM	2
Boyle, SH; Hall, R; Jiang, W; Krishnan, R; O'Connor, CM; Prybol, K; Rogers, JG; Steffens, DC; Streilein, RD; Xiong, GL	1
Alexopoulos, GS; Amore, M; Bagnoli, L; Belvederi Murri, M; Buffa, A; Cerri, M; Ferrara, S; Menchetti, M; Neri, M; Neviani, F; Rocchi, MB; Tam, E; Toni, G; Zanetidou, S; Zocchi, D	1
McMahon, FJ	1
Benseñor, IM; Brunoni, AR; Carvalho, AF; Cho, HJ; Gattaz, WF; Lotufo, PA; Machado-Vieira, R; Sampaio-Junior, B; Teixeira, AL; Valiengo, L; Vieira, EL	1
Allen, JJ; Lane, RD; Mercado, RA; Schafer, SM; Thayer, JF; Wager, TD	1
Arns, M; Debattista, C; Fallahpour, K; Fitzgerald, P; Gordon, E; Jongsma, ML; Kenemans, L; Kessels, RP; van Dinteren, R; Williams, LM	1
Akechi, T; Furukawa, TA; Guyatt, GH; Hayasaka, Y; Inagaki, M; Kato, T; Mantani, A; Miki, K; Ogawa, Y; Shimodera, S; Shinohara, K; Tajika, A; Takeshima, N; Tanaka, S; Watanabe, N; Yamada, M; Yonemoto, N	1
Chang, CC; Hsieh, YH; Ju, PC; Lai, TJ; Lan, TH; Lee, CT	1
Bech, P; Flint, AJ; Meyers, BS; Mulsant, BH; Rothschild, AJ; Vermeulen, T; Whyte, EM; Østergaard, SD	1
Almond, M; Chilcot, J; Davenport, A; Day, C; Farrington, K; Fineberg, N; Friedli, K; Gane, Mda S; Guirguis, A; Spencer, B; Wellsted, D	1
Bloch, MH; Freemantle, N; Jakubovski, E; Taylor, MJ; Varigonda, AL	1
Banerjee, S; Bingham, KS; Flint, AJ; Meyers, BS; Mulsant, BH; Rothschild, AJ; Whyte, EM	1
Cohen, S; Comstock, B; Cukor, D; Daniel, DM; Dember, LM; Diaz-Linhart, Y; Dubovsky, A; Greene, T; Grote, N; Heagerty, P; Hedayati, SS; Katon, W; Kimmel, PL; Kutner, N; Linke, L; Mehrotra, R; Quinn, D; Rue, T; Trivedi, MH; Unruh, M; Weisbord, S; Young, BA	1
Li, R; Mao, S; Sun, L; Yang, R; Zhao, Z	1
Baskak, B; Devrimci-Ozguven, H; Ozdemir, H; Ozel-Kizil, ET; Suzen, HS; Uckun, Z; Yuce-Artun, N	1
Blumenthal, JA; Hinderliter, AL; Hoffman, BM; Sherwood, A; Smith, PJ; Watkins, LL	1
Citrome, L	1
Adams, P; Bruder, G; Buckner, R; Carmody, TJ; Cooper, C; Fava, M; Grannemann, BD; Kraemer, HC; Kurian, BT; McGrath, PJ; McInnis, M; Morris, DW; Ogden, RT; Oquendo, MA; Parsey, RV; Petkova, E; Phillips, ML; Pizzagalli, D; Toups, M; Trivedi, MH; Weissman, MM; Weyandt, S	1
Dastgheib, SA; Mowla, A; Razeghian Jahromi, L	1
Gordon, E; Grieve, SM; Korgaonkar, MS; Rush, AJ; Williams, LM	1
Schwartz, TL	1
Benseñor, IM; Brunoni, AR; Carvalho, AF; Fregni, F; Lotufo, PA; Tortella, G	1
Dastgheib, SA; Firoozabadi, A; Heydari, M; Kolouri, S; Rezaeizadeh, H; Salehi, A; Zarshenas, MM	1
Asadpour, R; Bahramali, E; Erfani, N; Firouzabadi, N; Shayesteh, MR; Shoushtari, AA; Yavarian, I	1
Eriksson, E; Hieronymus, F; Nilsson, S	1
Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X	1
Brawman-Mintzer, O; Dauphin, M; Gao, J; Geibel, B; Madhoo, M; McIntyre, RS; Richards, C; Sambunaris, A; Weisler, R	1
Cheng, H; Gao, C; Li, S; Wu, X; Yang, J; Yang, R	1
Brooks, MM; Luther, JF; Potter, MA; Roberts, MS; Singh, A; Voorhees, RE; Wisniewski, SR	1
Alexopoulos, GS; Amore, M; Bagnoli, L; Belvederi Murri, M; Cabassi, A; Ceresini, G; Ermini, G; Menchetti, M; Mussi, C; Piepoli, M; Piras, A; Rucci, P; Senaldi, R; Squatrito, S; Toni, G; Tripi, F; Zanetidou, S; Zocchi, D	1
DeLucia, V; Kelsberg, G; Safranek, S	1
Aalto-Setälä, M; Brignone, M; Campbell, R; Cure, S; Danchenko, N; Diamand, F; Hallinen, T; Kolasa, K; Koponen, H; Soini, E	1
Gresky, DP; Ruble, MW; Treviño, K; Treviño, LA; Weinstein, LM	1
Imamura, Y; Mouri, A; Murakami, Y; Nabeshima, T; Saito, K; Tashiro, T; Yamamoto, Y	1
Mai, SM; Xiang, YT; Yang, XH; Zhang, YF; Zheng, W; Zhong, HQ	1
Alpert, JE; Baer, L; Clain, AJ; Cusin, C; Fava, M; Hylek, L; Ionescu, DF; Mischoulon, D; Soskin, DP; Yeung, AS	1
Buysse, DJ; Edinger, JD; Fairholme, CP; Gehrman, P; Krystal, AD; Luther, J; Manber, R; Thase, ME; Wisniewski, S	1
Amore, M; Asioli, F; Assirelli, B; Bagnoli, L; Belvederi Murri, M; Bertakis, KD; Luciano, C; Magagnoli, M; Masotti, M; Menchetti, M; Neri, M; Siena, M; Spezia, C; Toni, G; Zanetidou, S; Zocchi, D	1
Almond, M; Chilcot, J; Da Silva-Gane, M; Davenport, A; Day, C; Farrington, K; Fineberg, NA; Friedli, K; Guirguis, A; Spencer, B; Wellsted, D	1
Bhat, V; Margolese, HC	1
Le Foll, B; Samokhvalov, AV	1
Alexopoulos, GS; Banerjee, S; Butters, MA; Flint, AJ; Meyers, BS; Mulsant, BH; Rothschild, AJ; Victoria, LW; Whyte, EM	1
Bonaccorso, S; Girardi, P; Matrisciano, F; Nicoletti, F; Panaccione, I; Ricciardi, A; Ruberto, A; Scaccianoce, S; Shelton, RC; Tatarelli, R; Wang, L	1
Babyak, MA; Blumenthal, JA; Doraiswamy, PM; Hoffman, BM; Rogers, SD; Sherwood, A; Smith, PJ	1
Ghanizadeh, A	3
Preskorn, SH	2
Davis, LL; Fava, M; Luther, JF; Nierenberg, AA; Rush, AJ; Trivedi, MH; Warden, D; Wisniewski, SR	1
Dienel, A; Kasper, S; Kieser, M; Möller, HJ; Volz, HP	1
Buitelaar, JK; Roobol, TH	1
Cheung, A; Dubo, E; Garland, J; Kiss, A; Kusumakar, V; Kutcher, S; Levitt, A; Weiss, M	1
Hori, H; Ikenouchi-Sugita, A; Nakamura, J; Ueda, N; Umene-Nakano, W; Yoshimura, R	1
Kinoshita, T; Morishita, S	1
Balch, AH; Berman, RM; Boulton, DW; Mallikaarjun, S; Patel, CG; Reeves, RA; Royzman, K	1
Kostiukova, EG; Ladyzhenskiĭ, MIa; Mosolov, SN; Serditov, OV	1
Barbour, K; Burg, M; Jaffe, A; Taylor, CB; Trockel, M	1
Berger, M; Deimel, CM; Dykierek, P; Kech, S; Lieb, K; Schramm, E; van Calker, D; Zobel, I	1
Anthony, M; Davis, MF; Fankhauser, M; Freeman, MP; Fried, K; Moreno, F; Nolan, PE; Woosley, RL	1
Barbui, C; Churchill, R; Cipriani, A; Furukawa, TA; Geddes, JR; Malvini, L; McGuire, H; Nakagawa, A; Signoretti, A	1
Hurwitz, TD; Khawaja, IS; Schenck, CH	1
Bech, P; Dam, H; Lunde, M; Martiny, K; Undén, M	3
Hulstijn, W; Maas, YJ; Madani, Y; Pier, MP; Sabbe, BG; Schrijvers, D	1
Hanusa, BH; Lanza di Scalea, T; Wisner, KL	1
Cohen, BM; Forester, BP; Harper, DG; Jensen, JE; Jordan, B; Ravichandran, C; Renshaw, PF	1
Hassan, M; Marcus, SC; Olfson, M	1
Hautzinger, M; Hegerl, U; Helmreich, I; Henkel, V; Kohnen, R; Mergl, R; Tadić, A	1
Arnow, BA; Barkin, JL; Dowling, F; Klein, DN; Kocsis, JH; Leon, AC; Manber, R; Rothbaum, BO; Trivedi, MH; Wisniewski, SR	1
Konstantakopoulos, G; Kouzoupis, AV; Oulis, P; Papageorgiou, SG	1
Handa, T; Kashima, H; Kikuchi, T; Sawada, N; Suzuki, T; Uchida, H; Watanabe, K	1
Feeny, NC; Mavissakalian, MR; Roy-Byrne, PP; Zoellner, LA	1
Batzar, E; Fogel, I; Kremer, CM; Vanderburg, DG	1
Adler, LA; Amsterdam, JD; Dunner, DL; Michelson, D; Nierenberg, AA; Reimherr, FW; Schatzberg, AF; Williams, D	1
Caliyurt, O; Gorgulu, Y	1
Bahls, SC; Boeving, A; de Carvalho, GA; Graf, H	1
Flint, AJ; Heo, M; Leon, AC; Meyers, BS; Mulsant, BH; Papademetriou, E; Peasley-Miklus, C; Rothschild, AJ; Whyte, EM	1
Akkaya, C; Cangur, S; Eker, SS; Kirli, S; Sarandol, A	1
Biggio, G; Morgan, ML; Pisu, MG; Rapkin, AJ; Rasgon, N; Serra, M	1
Bigger, JT; Gaffney, M; Glassman, AH	1
Crain, AL; Godlevsky, OV; O'Connor, PJ; Wei, F; Whitebird, RR	1
Hori, H; Ikenouchi-Sugita, A; Nakamura, J; Otani, K; Suzuki, A; Ueda, N; Umene-Nakano, W; Yoshimura, R	1
Laje, G; McMahon, FJ; Perlis, RH; Rush, AJ	1
Fidaner, H; Gökmen, N; Mantar, A; Onur, E; Simsek, S; Yildiz, A	1
Iwata, N; Kawashima, K; Kinoshita, Y; Kishi, T; Kitajima, T; Naitoh, H; Nakamura, J; Okochi, T; Okumura, T; Ozaki, N; Tsunoka, T; Yamanouchi, Y; Yoshimura, R	1
Anderson, RJ; Freedland, KE; Gott, BM; Lustman, PJ; Sayuk, GS	1
Chaplin, W; Huertas, A; Huertas, SE; Juarbe, D; Perez-Pedrogo, C; Reyes-Rabanillo, ML; Reyes-Rodriguez, ML; Vera, M	1
Fukuo, Y; Iwata, N; Kawashima, K; Kinoshita, Y; Kishi, T; Kitajima, T; Naitoh, H; Nakamura, J; Okochi, T; Okumura, T; Ozaki, N; Tsunoka, T; Umene-Nakano, W; Yamanouchi, Y; Yoshimura, R	1
Baylé, FJ; Hajak, G; Hoogendijk, WJ; Kasper, S; Montejo, AL; Picarel-Blanchot, F; Quera-Salva, MA; Rybakowski, JK; Smeraldi, E; Wirz-Justice, AM; Wulff, K	1
Barch, DM; D'Angelo, G; Doraiswamy, PM; Garcia, KS; Gersing, K; Krishnan, RR; MacFall, JR; McKinstry, RC; Pieper, CF; Sheline, YI; Steffens, DC; Taylor, W; Welsh-Boehmer, K; Welsh-Bohmer, K; Wilkins, C	1
Anghelescu, I	1
Charles, D; Fava, M; Papakostas, GI	1
Dackis, CA; Dundon, WD; Gallis, TL; Kampman, KM; O'Brien, CP; Oslin, DW; Pettinati, HM; Xie, H	1
Butler, MC; Di Battista, M; Warden, M	1
Li, TK; Patkar, AA	1
Alpert, J; Cook, IA; DeBrota, D; Engelhardt, N; Kobak, KA; Leon, AC; Leuchter, A; Williams, JB	1
Nierenberg, AA; Schutte, AJ; Simmons, JH; Thase, ME; van Oers, HJ; Vrijland, P	1
Mori, N; Suda, S; Sugihara, G; Suyama, R; Takei, N	1
Bogetto, F; Chiadò Piat, S; Maina, G; Rigardetto, S; Rosso, G	1
Gorwood, P	1
Berlin, I; Chen, H; Covey, LS	1
Aggarwal, A; Jiloha, RC; Khandelwal, A	1
Baccaro, A; Bensenor, IM; Boggio, PS; Brunoni, AR; Bueno, VF; de Oliveira, JF; Fregni, F; Goulart, AC; Lotufo, PA; Valiengo, L; Vieira, GP; Zanao, TA	1
Akerblad, AC; Ekselius, L; Reis, M; von Knorring, L	1
Cooper, NJ; Gordon, E; Koslow, SH; Nemeroff, CB; Rush, AJ; Schatzberg, AF; Williams, LM; Wisniewski, SR	1
Blackburn, EH; Burke, H; Compagnone, M; Dhabhar, FS; Epel, ES; Lin, J; Mellon, SH; Nelson, JC; Reus, VI; Rosser, R; Wolkowitz, OM	1
Ameral, VE; Bitran, S; Clain, AJ; Farabaugh, AH; Fava, M; LaRocca, RA; Mischoulon, D	1
Kardeh, E; Mowla, A	1
Andreescu, C; Blumberger, DM; Emeremni, C; Flint, AJ; Houck, P; Mazumdar, S; Meyers, BS; Mulsant, BH; Rothschild, AJ; Whyte, E	1
Akechi, T; Furukawa, TA; Inagaki, M; Miki, K; Shimodera, S; Watanabe, N; Yamada, M; Yonemoto, N	1
Fukuo, Y; Inada, T; Iwata, N; Kawashima, K; Kishi, T; Kitajima, T; Kushima, I; Matsunaga, S; Naitoh, H; Nakamura, J; Okochi, T; Ozaki, N; Umene-Nakano, W; Yoshimura, R	1
Bot, M; Carney, RM; Freedland, KE; Mann, DL; Rich, MW; Rubin, EH; Steinmeyer, BC	1
Chen, YS; Chou, YH; Hsu, JW; Huang, CY; Su, TP	1
Jang, FL; Lin, CH; Lin, SH	1
Abe, T; Hirano, J; Kashima, H; Mimura, M; Nakajima, S; Suzuki, T; Takeuchi, H; Uchida, H; Watanabe, K; Yagihashi, T	1
Carney, RM; de Jonge, P; Freedland, KE; Meyer, H; Roest, AM; Rubin, EH; Stein, PK; Steinmeyer, BC	1
DeFife, JA; Dunlop, BW; Garlow, SJ; Lilienfeld, SO; Marx, L; Nemeroff, CB	1
Stewart, DE	1
Baillie, R; Cuffe, M; Fiuzat, M; Jiang, W; Kaddurah-Daouk, R; Krishnan, R; Kuchibhatla, M; Martsberger, C; O'Connor, C; Oken, H; Shaw, LK; Steffens, DC	1
Baer, L; Chen, JA; Clain, AJ; Fava, M; Mischoulon, D; Papakostas, GI; Youn, SJ	1
Huang, Y; Jin, Q; Li, J; Wu, L; Zhao, X; Zhu, G	1
Barber, JP; Barrett, MS; Gallop, R; Rickels, K; Rynn, MA	1
Bogdanov, MB; Boyle, SH; Churchill, E; Delnomdedieu, M; Kaddurah-Daouk, R; Krishnan, RR; Matson, S; Matson, W; Pickering, E; Rush, AJ; Sharma, S; Zhu, H	1
Dusetzina, SB; Ellis, AR; Farley, JF; Gaynes, BN; Hansen, RA; Miller, WC; Stürmer, T	1
Furuya, M; Horiguchi, J; Kunishige, K; Liaury, K; Miyaoka, T; Sadakuni, F; Wake, R	1
Kocsis, JH	1
Boku, S; Fujisawa, D; Honda, M; Inoue, T; Ishikane, T; Ito, K; Kawamura, K; Koyama, T; Matsubara, R; Ono, Y; Sasaki, K; Shinohara, K; Suzuki, T; Tsuchiya, K	1
Abbasi, SH; Akhondzadeh, S; Ashrafi, M; Hosseini, F; Modabbernia, A	1
Fava, M; Mischoulon, D; Sarris, J; Schweitzer, I	1
Diniz, BS; Forlenza, OV; Gattaz, WF; Joaquim, HP; Talib, LL	1
Akechi, T; Fujita, H; Furukawa, TA; Ikeda, Y; Inagaki, M; Kato, T; Kondo, M; Miki, K; Morokuma, I; Sato, H; Shimodera, S; Shinagawa, Y; Watanabe, N; Yamada, M; Yonemoto, N	1
Abbass, AA; Shedler, J; Town, JM	1
Afzali, S; Ghaleiha, A; Matinnia, N; Shahidi, KM	1
Cerit, C; Isik, S; Ozten, E; Tufan, AE	1
Tobe, E	1
Carroll, BJ; Chung, JW; Kim, DK; Kim, H; Kim, JW; Kim, S; Lim, SW; Myung, W; Seo, MY	1
Leelahanaj, T	1
Dunlop, BW; Garlow, SJ; Nemeroff, CB; Ninan, PT	1
Fava, M; Perlis, RH; Perroud, N; Uher, R	1
Schultz, SK	1
Burke, HM; Dhabhar, FS; Epel, ES; Hamilton, SP; Mellon, SH; Nelson, JC; Puterman, E; Rawdin, BJ; Reus, VI; Rosser, R; Su, Y; Wolkowitz, OM	1
Dundon, WD; O'Brien, CP; Pettinati, HM	1
Chung, CP; Morrow, JD; Salomon, RM; Schmidt, D; Stein, CM	1
Chaudron, LH	1
Adams, J; Graves, N; Solomon, D	1
Greenman, D; Kaufman, KR; Madraswala, R; Podolsky, D	1
Bogdanov, MB; Boyle, SH; Churchill, E; Delnomdedieu, M; Fiehn, O; Kaddurah-Daouk, R; Krishnan, RR; Pickering, E; Rush, AJ; Wang, Z; Wikoff, WR; Zhu, H	1
Dziurkowska, E; Dziurkowski, M; Wesolowski, M	1
Baccaro, A; Benseñor, IM; Boggio, PS; Brunoni, AR; de Oliveira, JF; Fregni, F; Goulart, A; Lotufo, PA; Valiengo, L; Zanão, TA	1
Kamijima, K; Ohishi, M	1
Barton, D; Bigger, JT; Califf, RM; Finkel, MS; Glassman, AH; Harrison, WM; Krishnan, KR; Landau, C; Mardekian, J; Mclvor, M; O'Connor, CM; Pepine, CJ; Schwartz, P; Shapiro, PA; Swedberg, K; Swenson, JR; van Zyl, LT	1
Carney, RM; Jaffe, AS	1
Muijsers, RB; Noble, S; Plosker, GL	2
Baca, E; García-Toro, M; González de Chávez, M; Pérez-Arnau, F; Porras-Chavarino, A	1
Datto, CJ; DiFilippo, SD; Katz, IR; Oslin, DW; Streim, JE; Weintraub, D	1
Boyer, P; Feiger, AD; Flament, MF; Gillespie, JA	1
Clary, CM; Krishnan, KR; Nelson, JC; Newhouse, P; Schneider, LS; Shiovitz, T; Weihs, K	1
Baido, RL; Boscati, L; Cerveri, G; Fiorentini, A; Invernizzi, G; Malvini, L; Mauri, MC; Regispani, F; Volonteri, LS	1
Jakovljević, M; Mihaljević-Peles, A; Mück-Seler, D; Mustapić, M; Pivac, N; Sagud, M	1
Ambrosini, P; Childress, A; Deas, D; Donnelly, C; Greenbaum, MS; Rynn, M; Wagner, KD; Wohlberg, C; Yang, R	1
Varley, CK	1
Clary, CM; Durham, LK; Milos, PM; Seymour, AB; Webb, SM	1
Chin, C; Cox, D; Epstein, L; Goldberg, A; Goodkin, D; Luks, TL; Mohr, DC; Nelson, S	1
Berman, SR; Fasiczka, AL; Friedman, ES; Howland, RH; Jindal, RD; Thase, ME	1
Anton, RF; Durazo-Arvizu, R; Latham, PK; Moak, DH; Voronin, KE; Waid, RL	1
Mathews, J; Mathews, M	1
Price, D	1
Solyom, AE	1
Spielmans, GI	1
Freeman, EW; Polansky, M; Rickels, K; Sondheimer, SJ; Xiao, S	1
Brandt, J; Lyketsos, CG; Munro, CA; Samus, Q; Steinberg, M; V Rabins, P	1
Anand, A; Berman, RM; Charney, DS; Lynch-Colonese, K; Perry, EB; Sanacora, G	1
Newcorn, JH	1
Hoenig, K; Kühn, KU; Maier, W; Quednow, BB; Stelzenmuelle, R; Wagner, M	1
Carroll, BJ	2
Fleming, MA; Frank, E; Scott, J; Shear, MK; Swartz, HA; Thase, ME	1
Garland, EJ	1
Balestrieri, M; Bergonzi, P; Cancelli, I; Marcon, G; Zamarian, L	1
Dudley, J; Mant, A; McManus, P; Mitchell, P	1
Aberg-Wistedt, A; Agren, H; Akerblad, AC; Bengtsson, F; Höglund, P; Reis, M	1
Ros, LT	1
Modestin, J; Tomaselli, G	1
Aberg-Wistedt, A; Agren, H; Akerblad, AC; Bengtsson, F; Reis, M	1
Allerup, P; Bech, P; Licht, RW; Qvitzau, S	1
Alajbegovic, L; Baghai, TC; Eser, D; Möller, HJ; Rupprecht, R; Schaaf, L; Schüle, C; Schwarz, M; Zwanzger, P	1
Gracious, BL; Hanusa, BH; Peindl, KS; Perel, JM; Wisner, KL	1
Le Mellédo, JM; Perez, J	1
Bennet, C; Jainer, AK; Smith, A	1
Adam, S; Bruyer, R; Constant, EL; Gillain, B; Seghers, A; Seron, X	1
Bastiaens, L	1
Dudley, AL; King, NJ; Melvin, GA; Tonge, BJ; Williams, NJ	1
Oslin, DW	1
Asberg, M; Bartfai, A; Berggren, AL; Landtblom, AM; Lundmark, J; Mårtensson, B; Murray, V; Näsman, P; Olsson, JE; Samuelsson, M; Terént, A; Varelius, R; von Arbin, M	1
Caliyurt, O; Guducu, F	2
Benuiwal, RP; Mendhekar, DN; Puri, V	1
Bair, MJ; Göbel, C; Löwe, B; Schenkel, I	1
Ozcanli, T; Ozdemir, S; Ozmen, M; Unsalver, B	1
De Ronchi, D; Franchini, L; Mandelli, L; Rossini, D; Serretti, A; Smeraldi, E; Zanardi, R	1
Lyketsos, CG; Mielke, MM; Rosenberg, PB	1
Burt, T; D'Souza, RF; George, T; Hopwood, M; Lam, W; Martin, AJ; Sir, A; Uguz, S; Vahip, S	1
Fava, M; Mallinckrodt, CH; Martinez, JM; Prakash, A; Watkin, JG; Wohlreich, MM	1
Arano, I; Burt, T; Cohen, G; Hamasaki, T; Kamijima, K	1
Allgaier, AK; Hegerl, U; Henkel, V; Kohnen, R; Mergl, R; Möller, HJ	1
Bickel, A; Kornhuber, J; Maihöfner, C; Ropohl, A	1
Abay, E; Caliyurt, O; Güdücü, F; Tuğlu, C; Vardar, E	1
Giordani, S; Lucca, A; Magri, L; Rossini, D; Smeraldi, E; Zanardi, R	1
Anthenelli, R; Brower, KJ; Cornelius, J; Hasin, D; Keller, M; Kranzler, HR; Martin, PR; Mason, BJ; Moak, D; Mueller, T; O'Malley, S; Pettinati, HM	1
Ibrahim Ramadan, M; Khan, AY; Weston, WE	1
Bria, P; Caltagirone, C; Ripa, A; Robinson, RG; Spalletta, G	1
Lavori, PW; Roose, SP; Sackeim, HA	1
Bigger, JT; Gaffney, M; Glassman, AH; Shapiro, PA; Swenson, JR	1
Arora, S; DeBattista, C; Fava, M; Hughes, RJ; Thase, ME	1
Biggs, MM; Fava, M; Luther, JF; Niederehe, G; Nierenberg, AA; Ritz, L; Rush, AJ; Shores-Wilson, K; Stewart, JW; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR	1
Antonini, A; Barone, P; Bracco, F; Marconi, R; Morgante, L; Musch, B; Scarzella, L; Zappia, M	1
Dinan, TG; O'Brien, SM; Scott, LV	1
Ciechanowski, PS; Clouse, RE; Freedland, KE; Gelenberg, AJ; Hirsch, IB; Lustman, PJ; McGill, JB; Nix, BD; Rubin, EH; Williams, MM	1
Bodnar, LM; Sunder, KR; Wisner, KL	1
Akerblad, AC; Bengtsson, F; Carlsson, A; Ekselius, L; von Knorring, L	1
Block, J	1
Akgoz, S; Akkaya, C; Kirli, S; Sarandol, A; Saygin Eker, S; Yazicioglu, B	1
Greenhill, LL; Moreno, C; Roche, AM	1
Di Loreto, G; Dionisio, P; Munizza, C; Olivieri, L	1
Gordon, MS; Heyne, D; King, NJ; Klimkeit, E; Melvin, GA; Tonge, BJ	1
Ambrosini, P; Donnelly, CL; Landau, P; Rynn, M; Wagner, KD; Wohlberg, CJ; Yang, R	1
Carroll, BJ; Chang, YH; Kim, DK; Kim, H; Kim, JW; Kim, S; Lim, SW	1
English, J; Flint, AJ; Gabriele, M; Heo, M; Meyers, BS; Mulsant, BH; Peasley-Miklus, C; Rothschild, AJ	1
Antonio, C; Maurizio, B; Silvia, M	1
Addington, D; Addington, J; Patten, S; Pierson, K	1
Bremner, JD; Charney, DS; Vermetten, E; Vythilingam, M	1
Dunner, DL; Haman, KL; Hirschfeld, RM; Kiev, A; Lydiard, RB; Rapaport, MH; Shelton, RC; Smith, WT; Zajecka, JM	1
Chiricolo, G; Cola, C; Di Lorenzo, G; Forleo, GB; Lauro, R; Leo, R; Razzini, C; Romeo, F; Siracusano, A; Tesauro, M; Troisi, A; Zanasi, M	1
Bharathi, V; Lee, FS	1
Barber, JP; Barrett, MS; Gallop, R; Iacoviello, BM; McCarthy, KS; Rynn, M	1
Roose, SP; Rutherford, BR	1
Colombo, C; De Ronchi, D; Mandelli, L; Rossini, D; Serretti, A; Tarricone, I; Zanardi, R	1
Fountoulakis, KN; Iacovides, A; Samolis, S; St Kaprinis, G	1
Connor, K; Davidson, JR; Vaishnavi, S	1
Ziegelstein, RC	1
Adler, LA; Amsterdam, JD; Dunner, DL; Kelsey, DK; Michelson, D; Nierenberg, AA; Reimherr, FW; Schatzberg, AF; Williams, DW	1
Berlin, F; Handel, S; Keach, S; Rao, V; Robbins, B; Spiro, J; Vaishnavi, S; Ward, J	1
Berger, M; Dykierek, P; Kech, S; Leonhart, R; Lieb, K; Schramm, E; van Calker, D; Zobel, I	1
Boovariwala, A; Ginovart, N; Houle, S; Meyer, JH; Rusjan, P; Sagrati, S; Sokolov, S; Spencer, EP; Voineskos, AN; Wilson, AA	1
Apter, JT; Cohen, R; Cooper-Kazaz, R; Drori, T; Glaser, B; Grupper, D; Karagichev, L; Lerer, B; Muhammed-Moussa, S; Newman, ME; Sackeim, HA	1
Alexopoulos, GS; Keilp, JG; Krishnan, KR; Roose, SP; Sackeim, HA; Sneed, JR	1
Delucchi, K; Nelson, JC; Schneider, L	1
Clary, CM; Harvey, AT; Kornstein, SG; Silkey, BS	1
Dupuy, JB; Ladouceur, R	1
Badyal, DK; Deswal, RS; Khosla, P; Matreja, PS	1
Amsterdam, JD; Dunner, DL; Loebel, A; Romano, SJ; Shelton, RC	1
Bigger, JT; Gaffney, M; Glassman, AH; Van Zyl, LT	1
Benattia, I; Demitrack, M; Entsuah, R; Nemeroff, CB; Sloan, DM; Thase, ME	1
Shelton, RC	1
Burrows, G; Jefferys, D	1
Jagadheesan, K; Lusicic, A	1
Berger, M; Dykierek, P; Härter, M; Kech, S; Schneider, D; Schramm, E; van Calker, D; Zobel, I	1
Aker, AT; Ozdemir, S; Yalug, I	1
Cooke, C; Gardner, D; Kisely, S; Sketris, I; Smith, AJ; Tett, SE	1
Ford, JS	1
Bozkurt, A; Cansever, A; Musabak, U; Oktenli, C; Ozmenler, N; Ozsahin, A; Sanisoglu, SY; Sengul, A; Sutcigil, L; Uzun, O; Yesilova, Z	1
Berman, RM; Carson, WH; Fava, M; Hennicken, D; Marcus, RN; McQuade, RD; Simon, JS; Thase, ME; Trivedi, MH	1
Ishii, M; Nomura, S; Tatsuzawa, Y; Yoshino, A	1
Binneman, B; Feltner, D; Kolluri, S; Qiu, R; Shi, Y; Stiger, T	1
Helsel, JC; Perel, JM; Sit, DK; Wisner, KL	1
Beekman, AT; Comijs, HC; Deeg, DJ; Sonnenberg, CM; van Tilburg, W	1
Dogan, O; Ergun, MA; Ilhan, MN; Karslioglu, HE; Koc, A; Menevse, A; Yilmaz, A; Yuksel, N	1
Baker, B; Dorian, P; Frasure-Smith, N; Glassman, AH; Harrison, W; Jiang, JW; Lespérance, F; O'Connor, CM; Shapiro, PA	1
Ascher, JA; Batey, SR; Croft, H; Donahue, RM; Houser, T; Settle, E	1
Batzar, E; Clary, CM; Finkel, SI; Richter, EM	1
Bagby, RM; Joffe, RT; Kennedy, SH; Levitan, RD; Levitt, AJ	1
Boyer, P; Paternetti, S; Sechter, D; Troy, S	1
Ascher, JA; Batey, SR; Coleman, CC; Cunningham, LA; Donahue, RM; Foster, VJ; Houser, TL	1
Chiu, E; George, T; Hokin, A; Krapivensky, N; Theodoros, MT; Tiller, JW	1
Saraf, M; Schrader, G	1
Anisman, H; Griffiths, J; Merali, Z; Ravindran, AV; Zaharia, MD	1
Breen, JA; DeBattista, C; Schatzberg, AF; Solvason, HB	1
Hostetter, A; Llewellyn, A; McLaughlin, E; Stowe, ZN; Strader, JR	1
Gentilini, G; Lopez-Silva, S; Lucca, A; Soldarini, A	1
Dietrich, AJ	1
Cheung, SW; Otton, SV; Romach, MK; Sellers, EM; Sproule, BA; Zhong, XH	1
Aberg-Wistedt, A; Agren, H; Akerblad, AC; Bengtsson, F; Ekselius, L	1
Glaser, K; Göbel, C; Leverkus, F; Möller, HJ	1
Braus, DF; Schmitt, A	1
Davis, S; Friedman, ES; Harrison, W; Hirschfeld, RM; Keller, M; Koran, LM; Rush, J; Russell, JM	1
Ekselius, L; von Knorring, L	1
Cook, IA; Leuchter, AF	1
Almeida, OP; Forlenza, OV; Hirata, ES; Stoppe, A	1
Demartinis, N; García-España, F; Mandos, LA; Rickels, K; Rynn, M; Schweizer, E	1
Ascher, JA; Batey, SR; Bolden-Watson, C; Carmody, TJ; Donahue, RM; Houser, TL; Metz, A; Rush, AJ; Trivedi, MH	1
DeBattista, C; Friedman, RA; Gelenberg, AJ; Hirschfeld, RM; Howland, RH; Keller, MB; Klein, D; Kocsis, JH; Koran, LM; Kornstein, SG; LaVange, LM; Rush, AJ; Schatzberg, AF; Thase, ME	1
Burt, T; Lane, RM	1
Alpert, M; Pouget, ER; Silva, RR	1
Arnillas, H; Capllonch, I; García-Toro, M; González, A; Ibarra, O; Mayol, A; Micó, J; Pascual-Leone, A; Romera, M; Tormos, JM	1
Barch, DM; Donnelly, JM; Mintun, MA; Ollinger, JM; Sheline, YI; Snyder, AZ	1
Greenberg, BD; Hoehn-Saric, R; McLeod, DR; Pearlson, GD; Schlaepfer, TE; Wong, SH	1
Clary, CM; Schneider, LS; Small, GW	1
Bostrom, A; Boudewyn, AC; Epstein, L; Goodkin, DE; Mohr, DC	1
Addington, D; Addington, J; Beauclair, L; Labelle, A; Moamai, J; Patten, S; Remington, G	1
Bolden-Watson, C; Carmody, TJ; Donahue, RM; Houser, TL; Metz, A; Rush, AJ; Trivedi, MH	1
Härter, M; Hesslinger, B; Klecha, D; Schmidt-Schweda, S; Van de Loo, A	1
Fawcett, J; Gelenberg, AJ; Harrison, W; Hirschfeld, RM; Howland, RH; Keller, MB; Klein, DN; Kocsis, JH; Koran, LM; Kornstein, SG; LaVange, LM; Rush, AJ; Russell, JM; Schatzberg, AF; Thase, ME	1
Fava, M; Gonzales, JS; Hoog, SL; Judge, RA; Kopp, JB; Nilsson, ME	1
Bagby, RM; Kennedy, SH; Vanderkooy, JD	1
Brown, EB; Gonzales, JS; Miner, CM; Munir, R	1
Binanay, C; Califf, RM; Cole, JO; Davidson, JR; de Battista, C; Doraiswamy, PM; Fairbank, JA; Feighner, JP; Gadde, KM; Hartwell, TD; Keck, P; Kelsey, J; Krishnan, KRR; Lin, KM; Londborg, PD; Nemeroff, CB; Parker, CB; Pugh, N; Ritz, L; Schatzberg, AF; Severe, J; Sheehan, DV; Srivastava, RK; Taylor, L; Trivedi, MH; Vitiello, B; Weisler, RH	1
Licht, RW; Qvitzau, S	1
Hadrava, V; Kutcher, S; Leblanc, J; Maclaren, C	1
Boscati, L; Cerveri, G; Laini, V; Malvini, L; Manfré, S; Mauri, MC; Panza, G; Regispani, F; Scalvini, ME; Volonteri, LS	1
Bell, B; Browne, G; Byrne, C; Chalklin, L; Dunn, E; Gafni, A; Kraemer, J; Mills, M; Roberts, J; Steiner, M; Wallik, D	1

Reviews

27 review(s) available for sertraline and Depression, Involutional

Article	Year
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis. Molecular psychiatry, 2023, Volume: 28, Issue:1 Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Fluvoxamine; Humans; Mirtazapine; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Sertraline; Venlafaxine Hydrochloride; Vortioxetine	2023
Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2022, Aug-01, Volume: 51, Issue:4 Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Fluoxetine; Humans; Imipramine; Network Meta-Analysis; Paroxetine; Sertraline; Venlafaxine Hydrochloride	2022
Pharmacologic and psychological interventions for depression treatment in patients with kidney disease. Current opinion in nephrology and hypertension, 2020, Volume: 29, Issue:5 Topics: Antidepressive Agents; Cognitive Behavioral Therapy; Depressive Disorder, Major; Humans; Kidney Failure, Chronic; Renal Insufficiency, Chronic; Selective Serotonin Reuptake Inhibitors; Sertraline	2020
New generation antidepressants for depression in children and adolescents: a network meta-analysis. The Cochrane database of systematic reviews, 2021, 05-24, Volume: 5 Topics: Adolescent; Antidepressive Agents; Bias; Child; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mirtazapine; Network Meta-Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicidal Ideation; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine	2021
Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled Trials. Psychotherapy and psychosomatics, 2017, Volume: 86, Issue:5 Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2017
Specificity profile of venlafaxine and sertraline in major depression: metaregression of double-blind, randomized clinical trials. The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:1 Topics: Adrenergic Uptake Inhibitors; Cyclohexanols; Demography; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Randomized Controlled Trials as Topic; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride	2014
A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike? International clinical psychopharmacology, 2014, Volume: 29, Issue:4 Topics: Allosteric Site; Animals; Antidepressive Agents, Second-Generation; Citalopram; Depression; Depressive Disorder, Major; Drug Interactions; Evidence-Based Medicine; Humans; Models, Biological; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline	2014
Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies. Current medical research and opinion, 2014, Volume: 30, Issue:12 Topics: Acetamides; Adult; Aged; Antidepressive Agents; Benzofurans; Citalopram; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Humans; Hypnotics and Sedatives; Indoles; Male; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulfides; Thiophenes; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine	2014
Adolescent angst or true intent? Suicidal behavior, risk, and neurobiological mechanisms in depressed children and teenagers taking antidepressants. International journal of emergency mental health, 2014, Volume: 16, Issue:1 Topics: Adolescent; Antidepressive Agents; Anxiety Disorders; Bipolar Disorder; Brain; Depressive Disorder, Major; Feedback, Physiological; Female; Homicide; Humans; Neurons; Patient Admission; Raphe Nuclei; Receptor, Serotonin, 5-HT1A; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Substance Withdrawal Syndrome; Suicidal Ideation	2014
Hypersexuality after self-inflicted nail gun penetrating traumatic brain injury and neurosurgery: case analysis with literature review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2015, Volume: 27, Issue:1 Topics: Adult; Antidepressive Agents; Brain Injuries; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Humans; Male; Neurosurgery; Paraphilic Disorders; Self-Injurious Behavior; Sertraline; Suicide, Attempted	2015
[Venlafaxine-induced delirium mediated by high doses]. Revista de neurologia, 2015, May-16, Volume: 60, Issue:10 Topics: Aged; Antidepressive Agents; Comorbidity; Confusion; Delirium; Depressive Disorder, Major; Dopamine; Dose-Response Relationship, Drug; Drug Substitution; Drug Synergism; Female; Humans; Lorazepam; Models, Neurological; Norepinephrine; Polypharmacy; Psychotropic Drugs; Recurrence; Sertraline; Venlafaxine Hydrochloride	2015
Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder. The American journal of psychiatry, 2016, Feb-01, Volume: 173, Issue:2 Topics: Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2016
Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed. Journal of affective disorders, 2016, May-15, Volume: 196 Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Vilazodone Hydrochloride	2016
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet (London, England), 2016, Aug-27, Volume: 388, Issue:10047 Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride	2016
Wuling Capsule for Major Depressive Disorder: A Meta-analysis of Randomised Controlled Trials. East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan, 2016, Volume: 26, Issue:3 Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; China; Depressive Disorder, Major; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Sertraline; Treatment Outcome; Young Adult	2016
Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:11 Topics: Acute Disease; Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Humans; Patient Dropouts; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2008
Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2010, Volume: 11, Issue:2 Pt 2 Topics: Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2010
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression. International clinical psychopharmacology, 2010, Volume: 25, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Patient Dropouts; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult	2010
Restoring circadian rhythms: a new way to successfully manage depression. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:2 Suppl Topics: Acetamides; Animals; Antidepressive Agents; Circadian Rhythm; Depressive Disorder, Major; Humans; Remission Induction; Sertraline; Time Factors	2010
Current status of co-occurring mood and substance use disorders: a new therapeutic target. The American journal of psychiatry, 2013, Volume: 170, Issue:1 Topics: Alcoholism; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Controlled Clinical Trials as Topic; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Double-Blind Method; Drug Therapy, Combination; Humans; Mood Disorders; Naltrexone; Narcotic Antagonists; Psychotropic Drugs; Sertraline; Substance-Related Disorders	2013
Complex challenges in treating depression during pregnancy. The American journal of psychiatry, 2013, Volume: 170, Issue:1 Topics: Abnormalities, Drug-Induced; Adult; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Psychotherapy; Recurrence; Risk Assessment; Sertraline	2013
Spotlight on sertraline in the management of major depressive disorder in elderly patients. CNS drugs, 2002, Volume: 16, Issue:11 Topics: Aged; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder, Major; Humans; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2002
Treatment of depression with atypical features: a meta-analytic approach. Psychiatry research, 2006, Jan-30, Volume: 141, Issue:1 Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Phenelzine; Sertraline; Severity of Illness Index	2006
Pharmacotherapy of child and adolescent depression. Child and adolescent psychiatric clinics of North America, 2006, Volume: 15, Issue:4 Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Depressive Disorder, Major; Fluoxetine; Humans; Paroxetine; Sertraline; Social Behavior	2006
Differences in generic sertraline for children: real or artefact from cost containing to clinical quality of generics use. European journal of clinical pharmacology, 2006, Volume: 62, Issue:12 Topics: Antidepressive Agents; Child; Child Health Services; Cost-Benefit Analysis; Depressive Disorder, Major; Drugs, Generic; Humans; Obsessive-Compulsive Disorder; Quality Assurance, Health Care; Sertraline	2006
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs. Biological psychiatry, 2008, Feb-15, Volume: 63, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride	2008
Sertraline: a review of its use in the management of major depressive disorder in elderly patients. Drugs & aging, 2002, Volume: 19, Issue:5 Topics: Adolescent; Adult; Age Factors; Aged; Alzheimer Disease; Comorbidity; Depressive Disorder, Major; Humans; MEDLINE; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline	2002

Trials

259 trial(s) available for sertraline and Depression, Involutional

Article	Year
Patterns of Pretreatment Reward Task Brain Activation Predict Individual Antidepressant Response: Key Results From the EMBARC Randomized Clinical Trial. Biological psychiatry, 2022, 03-15, Volume: 91, Issue:6 Topics: Antidepressive Agents; Biomarkers; Brain; Bupropion; Calcium Phosphates; Depressive Disorder, Major; Humans; Reward; Sertraline; Treatment Outcome	2022
Effects of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, on Perceived Stress and Cognitive Function Among Patients With Late-Life Depression: A Randomized, Double-Blind, Sertraline- and Placebo-Controlled Trial. The international journal of neuropsychopharmacology, 2022, 08-04, Volume: 25, Issue:7 Topics: Aged; Cognition; Depressive Disorder, Major; Double-Blind Method; Humans; Middle Aged; Oxidoreductases; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate; Selective Serotonin Reuptake Inhibitors; Sertraline; Sodium Benzoate; Stress, Psychological; Treatment Outcome	2022
Cilostazol as an adjunctive treatment in major depressive disorder: a pilot randomized, double-blind, and placebo-controlled clinical trial. Psychopharmacology, 2022, Volume: 239, Issue:2 Topics: Cilostazol; Depressive Disorder, Major; Double-Blind Method; Humans; Iran; Pilot Projects; Sertraline; Treatment Outcome	2022
Association of serotonin transporter gene polymorphism with efficacy of the antidepressant drugs sertraline and mirtazapine in newly diagnosed patients with major depressive disorders. Human psychopharmacology, 2022, Volume: 37, Issue:4 Topics: Antidepressive Agents; Depressive Disorder, Major; Humans; Mirtazapine; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Treatment Outcome	2022
Dynamic Resting-State Network Biomarkers of Antidepressant Treatment Response. Biological psychiatry, 2022, 10-01, Volume: 92, Issue:7 Topics: Adult; Antidepressive Agents; Biomarkers; Brain; Depressive Disorder, Major; Humans; Magnetic Resonance Imaging; Sertraline	2022
EEG Biomarkers to Predict Response to Sertraline and Placebo Treatment in Major Depressive Disorder. IEEE transactions on bio-medical engineering, 2023, Volume: 70, Issue:3 Topics: Antidepressive Agents; Biomarkers; Depressive Disorder, Major; Electroencephalography; Humans; Sertraline	2023
Increased immuno-inflammatory mediators in women with post-traumatic stress disorder after sexual assault: 1-Year follow-up. Journal of psychiatric research, 2022, Volume: 155 Topics: Adrenocorticotropic Hormone; Biomarkers; C-Reactive Protein; Chemokine CCL2; Depressive Disorder, Major; Female; Follow-Up Studies; Humans; Hydrocortisone; Inflammation Mediators; Interleukin-1beta; Sertraline; Sex Offenses; Stress Disorders, Post-Traumatic; Tumor Necrosis Factor-alpha	2022
Accelerated Brain Aging in Adults With Major Depressive Disorder Predicts Poorer Outcome With Sertraline: Findings From the EMBARC Study. Biological psychiatry. Cognitive neuroscience and neuroimaging, 2023, Volume: 8, Issue:4 Topics: Adult; Aging; Antidepressive Agents; Biomarkers; Brain; Depressive Disorder, Major; Female; Humans; Infant; Infant, Newborn; Male; Reproducibility of Results; Sertraline	2023
Predictors of response to pharmacotherapy in children and adolescents with psychiatric disorders: A combined post hoc analysis of four clinical trial data. Neuropsychopharmacology reports, 2022, Volume: 42, Issue:4 Topics: Adolescent; Child; Depressive Disorder, Major; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States	2022
Individualized fMRI connectivity defines signatures of antidepressant and placebo responses in major depression. Molecular psychiatry, 2023, Volume: 28, Issue:6 Topics: Antidepressive Agents; Brain; Depression; Depressive Disorder, Major; Double-Blind Method; Humans; Magnetic Resonance Imaging; Sertraline; Treatment Outcome	2023
l-theanine adjunct to sertraline for major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial. Journal of affective disorders, 2023, 07-15, Volume: 333 Topics: Depressive Disorder, Major; Double-Blind Method; Glutamates; Humans; Sertraline; Treatment Outcome	2023
The relationship of white matter microstructure with psychomotor disturbance and relapse in remitted psychotic depression. Journal of affective disorders, 2023, 08-01, Volume: 334 Topics: Anisotropy; Brain; Depression; Depressive Disorder, Major; Humans; Psychotic Disorders; Sertraline; White Matter	2023
Effects of antipsychotic medication on functional connectivity in major depressive disorder with psychotic features. Molecular psychiatry, 2023, Volume: 28, Issue:8 Topics: Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Magnetic Resonance Imaging; Olanzapine; Sertraline	2023
Effects of Aphrodite (an Herbal Compound) on SSRI-Induced Sexual Dysfunctions and Depression in Females with Major Depressive Disorder: Findings from a Randomized Clinical Trial. Medicina (Kaunas, Lithuania), 2023, Sep-14, Volume: 59, Issue:9 Topics: Adult; Depression; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological	2023
Rapid improvements and subsequent effects in major depressive disorder patients with somatic pain using rTMS combined with sertraline. Scientific reports, 2023, 10-20, Volume: 13, Issue:1 Topics: Depressive Disorder, Major; Humans; Nociceptive Pain; Prefrontal Cortex; Sertraline; Transcranial Magnetic Stimulation; Treatment Outcome	2023
Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial. JAMA, 2019, 08-20, Volume: 322, Issue:7 Topics: Adolescent; Adult; Affective Disorders, Psychotic; Aged; Antidepressive Agents; Antipsychotic Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Proportional Hazards Models; Secondary Prevention; Sertraline; Young Adult	2019
Normalization of EEG in depression after antidepressant treatment with sertraline? A preliminary report. Journal of affective disorders, 2019, 12-01, Volume: 259 Topics: Adult; Alpha Rhythm; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Electroencephalography; Female; Humans; Male; Middle Aged; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2019
Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals. Molecular psychiatry, 2020, Volume: 25, Issue:7 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Female; Humans; Male; Reward; Sertraline; Ventral Striatum	2020
Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major Depression. The American journal of psychiatry, 2020, 02-01, Volume: 177, Issue:2 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Brain; Depressive Disorder, Major; Female; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Predictive Value of Tests; Sertraline; Treatment Outcome; Young Adult	2020
Connectivity of the Cognitive Control Network During Response Inhibition as a Predictive and Response Biomarker in Major Depression: Evidence From a Randomized Clinical Trial. Biological psychiatry, 2020, 03-01, Volume: 87, Issue:5 Topics: Biomarkers; Cognition; Depression; Depressive Disorder, Major; Humans; Magnetic Resonance Imaging; Sertraline; Treatment Outcome	2020
Crocus Sativus L. (saffron) versus sertraline on symptoms of depression among older people with major depressive disorders-a double-blind, randomized intervention study. Psychiatry research, 2019, Volume: 282 Topics: Aged; Antidepressive Agents; Crocus; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Phytotherapy; Plant Extracts; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2019
Intrinsic connectomes are a predictive biomarker of remission in major depressive disorder. Molecular psychiatry, 2020, Volume: 25, Issue:7 Topics: Adult; Antidepressive Agents; Biomarkers; Brain; Citalopram; Connectome; Depressive Disorder, Major; Female; Humans; Magnetic Resonance Imaging; Male; Neural Pathways; Remission Induction; Sertraline; Venlafaxine Hydrochloride; Young Adult	2020
Stability of frontal alpha asymmetry in depressed patients during antidepressant treatment. NeuroImage. Clinical, 2019, Volume: 24 Topics: Adult; Alpha Rhythm; Antidepressive Agents; Biomarkers; Citalopram; Depressive Disorder, Major; Electroencephalography; Female; Frontal Lobe; Functional Laterality; Humans; Male; Prospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2019
Cortical Connectivity Moderators of Antidepressant vs Placebo Treatment Response in Major Depressive Disorder: Secondary Analysis of a Randomized Clinical Trial. JAMA psychiatry, 2020, 04-01, Volume: 77, Issue:4 Topics: Adolescent; Adult; Aged; Alpha Rhythm; Brain; Depressive Disorder, Major; Electroencephalography; Female; Gamma Rhythm; Humans; Linear Models; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult	2020
Antidepressants effects of Rhodiola capsule combined with sertraline for major depressive disorder: A randomized double-blind placebo-controlled clinical trial. Journal of affective disorders, 2020, 03-15, Volume: 265 Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Humans; Psychiatric Status Rating Scales; Quality of Life; Rhodiola; Sertraline; Treatment Outcome	2020
Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial. JAMA psychiatry, 2020, 07-01, Volume: 77, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Cerebral Cortex; Depressive Disorder, Major; Diffusion Tensor Imaging; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Outcome Assessment, Health Care; Psychotic Disorders; Sertraline; White Matter; Young Adult	2020
Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: A double-blind randomized trial. Journal of clinical pharmacy and therapeutics, 2020, Volume: 45, Issue:4 Topics: Aged; Aged, 80 and over; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Sertraline; Vortioxetine	2020
Effects of transcranial direct current stimulation using miniaturized devices vs sertraline for depression in Korea: A 6 week, multicenter, randomized, double blind, active-controlled study. Journal of psychiatric research, 2020, Volume: 127 Topics: Depression; Depressive Disorder, Major; Double-Blind Method; Humans; Republic of Korea; Sertraline; Transcranial Direct Current Stimulation; Treatment Outcome	2020
Pretreatment Reward Sensitivity and Frontostriatal Resting-State Functional Connectivity Are Associated With Response to Bupropion After Sertraline Nonresponse. Biological psychiatry, 2020, 10-15, Volume: 88, Issue:8 Topics: Adult; Bupropion; Depressive Disorder, Major; Humans; Prospective Studies; Reward; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2020
Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial. JAMA network open, 2020, 06-01, Volume: 3, Issue:6 Topics: Adult; Algorithms; Antidepressive Agents; Citalopram; Clinical Decision Rules; Depressive Disorder, Major; Electroencephalography; Female; Humans; Machine Learning; Male; Middle Aged; Prognosis; Prospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2020
Improvements in irritability with sertraline versus placebo: Findings from the EMBARC study. Journal of affective disorders, 2020, 10-01, Volume: 275 Topics: Calcium Phosphates; Depressive Disorder, Major; Double-Blind Method; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2020
Can personalized treatment prediction improve the outcomes, compared with the group average approach, in a randomized trial? Developing and validating a multivariable prediction model in a pragmatic megatrial of acute treatment for major depression. Journal of affective disorders, 2020, 09-01, Volume: 274 Topics: Antidepressive Agents; Depression; Depressive Disorder, Major; Humans; Precision Medicine; Sertraline; Treatment Outcome	2020
What to Expect When Switching to a Second Antidepressant Medication Following an Ineffective Initial SSRI: A Report From the Randomized Clinical STARD Study. The Journal of clinical psychiatry, 2020, 08-11, Volume: 81, Issue:5* Topics: Adult; Antidepressive Agents; Bupropion; Delayed-Action Preparations; Depressive Disorder, Major; Drug Substitution; Female; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2020
The role of comorbid anxiety in exercise and depression trials: Secondary analysis of the SMILE-II randomized clinical trial. Depression and anxiety, 2021, Volume: 38, Issue:2 Topics: Adult; Anxiety; Depression; Depressive Disorder, Major; Exercise; Humans; Sertraline; Treatment Outcome	2021
Dorsolateral Prefrontal Cortex and Subcallosal Cingulate Connectivity Show Preferential Antidepressant Response in Major Depressive Disorder. Biological psychiatry. Cognitive neuroscience and neuroimaging, 2021, Volume: 6, Issue:1 Topics: Antidepressive Agents; Depressive Disorder, Major; Gyrus Cinguli; Humans; Prefrontal Cortex; Sertraline	2021
Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial. Psychological medicine, 2022, Volume: 52, Issue:13 Topics: Antidepressive Agents; Bupropion; Depressive Disorder, Major; Double-Blind Method; Humans; Sertraline; Treatment Outcome	2022
Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial. International clinical psychopharmacology, 2021, 05-01, Volume: 36, Issue:3 Topics: Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Humans; Pentoxifylline; Sertraline; Treatment Outcome	2021
Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report. Translational psychiatry, 2021, 08-04, Volume: 11, Issue:1 Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Humans; Sertraline; Treatment Outcome	2021
Associations between symptoms of depression and heart rate variability: An exploratory study. Psychiatry research, 2018, Volume: 262 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Female; Heart Rate; Humans; Male; Middle Aged; Sertraline; Transcranial Direct Current Stimulation	2018
Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial. JAMA, 2017, 11-21, Volume: 318, Issue:19 Topics: Adult; Antidepressive Agents; Depression; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Quality of Life; Renal Insufficiency, Chronic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2017
Increased hippocampal tail volume predicts depression status and remission to anti-depressant medications in major depression. Molecular psychiatry, 2018, Volume: 23, Issue:8 Topics: Adult; Age Factors; Antidepressive Agents; Citalopram; Cohort Studies; Delayed-Action Preparations; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Hippocampus; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Organ Size; Pattern Recognition, Automated; Prognosis; Psychiatric Status Rating Scales; Remission Induction; Sertraline; Venlafaxine Hydrochloride	2018
Physical exercise for late-life depression: Effects on symptom dimensions and time course. Journal of affective disorders, 2018, 04-01, Volume: 230 Topics: Aged; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder, Major; Exercise; Exercise Therapy; Female; Heart Rate; Humans; Male; Sertraline; Time Factors; Treatment Outcome	2018
Pretreatment Rostral Anterior Cingulate Cortex Theta Activity in Relation to Symptom Improvement in Depression: A Randomized Clinical Trial. JAMA psychiatry, 2018, 06-01, Volume: 75, Issue:6 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Electroencephalography; Female; Gyrus Cinguli; Humans; Male; Middle Aged; Prognosis; Sertraline; Theta Rhythm; Treatment Outcome; Young Adult	2018
Randomized, double-blind comparison of aripiprazole/sertraline combination and placebo/sertraline combination in patients with major depressive disorder. Psychiatry and clinical neurosciences, 2018, Volume: 72, Issue:8 Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nasopharyngitis; Outcome Assessment, Health Care; Sertraline; Single-Blind Method; Young Adult	2018
Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study. Psychological medicine, 2019, Volume: 49, Issue:7 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Endophenotypes; Female; Humans; Machine Learning; Male; Middle Aged; Patient Outcome Assessment; Precision Medicine; Prospective Studies; Sertraline; Treatment Outcome; Young Adult	2019
Efficacy of Sertraline in Patients With Major Depressive Disorder Naive to Selective Serotonin Reuptake Inhibitors: A 10-Week Randomized, Multicenter, Placebo-Controlled, Double-Blind, Academic Clinical Trial. Journal of clinical psychopharmacology, 2018, Volume: 38, Issue:5 Topics: Adult; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult	2018
Heart rate variability as a biomarker of anxious depression response to antidepressant medication. Depression and anxiety, 2019, Volume: 36, Issue:1 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Biomarkers; Citalopram; Depression; Depressive Disorder, Major; Female; Heart Rate; Humans; Male; Middle Aged; Prognosis; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2019
The Concise Health Risk Tracking-Self Report: Psychometrics within a placebo-controlled antidepressant trial among depressed outpatients. Journal of psychopharmacology (Oxford, England), 2019, Volume: 33, Issue:2 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Self Report; Sertraline; Suicidal Ideation; Young Adult	2019
Pretreatment Rostral Anterior Cingulate Cortex Connectivity With Salience Network Predicts Depression Recovery: Findings From the EMBARC Randomized Clinical Trial. Biological psychiatry, 2019, 05-15, Volume: 85, Issue:10 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Female; Gyrus Cinguli; Humans; Male; Middle Aged; Neural Pathways; Sertraline; Theta Rhythm; Treatment Outcome	2019
Brain functional alterations observed 4-weekly in major depressive disorder following antidepressant treatment. Journal of affective disorders, 2019, 06-01, Volume: 252 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Female; Hemodynamics; Humans; Longitudinal Studies; Male; Oxyhemoglobins; Prefrontal Cortex; Psychiatric Status Rating Scales; Sertraline; Spectroscopy, Near-Infrared; Time Factors; Treatment Outcome; Young Adult	2019
Dimensions of anxiety in Major depressive disorder and their use in predicting antidepressant treatment outcome: an iSPOT-D report. Psychological medicine, 2020, Volume: 50, Issue:6 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Citalopram; Cognition; Depressive Disorder, Major; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychometrics; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2020
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study. The American journal of psychiatry, 2019, 06-01, Volume: 176, Issue:6 Topics: Administration, Intranasal; Administration, Oral; Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Ketamine; Male; Middle Aged; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2019
A Randomized Placebo-Controlled Trial of Omega-3 and Sertraline in Depressed Patients With or at Risk for Coronary Heart Disease. The Journal of clinical psychiatry, 2019, 06-04, Volume: 80, Issue:4 Topics: Antidepressive Agents; Coronary Disease; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Dietary Supplements; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Treatment Outcome	2019
A Trial of Sertraline or Cognitive Behavior Therapy for Depression in Epilepsy. Annals of neurology, 2019, Volume: 86, Issue:4 Topics: Adult; Aged; Cognitive Behavioral Therapy; Depressive Disorder, Major; Epilepsy; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult	2019
The incidence of tardive dyskinesia in the study of pharmacotherapy for psychotic depression. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:3 Topics: Age Factors; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Incidence; Middle Aged; Olanzapine; Prevalence; Psychotic Disorders; Risk Factors; Sertraline; Time Factors	2013
Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2013, Volume: 23, Issue:11 Topics: Adolescent; Adult; Aged; Alleles; Brain-Derived Neurotrophic Factor; Combined Modality Therapy; Depressive Disorder, Major; Double-Blind Method; Electric Stimulation Therapy; Epistasis, Genetic; Female; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Serotonergic Neurons; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline; Treatment Outcome	2013
The sertraline versus electrical current therapy for treating depression clinical study (select-TDCS): results of the crossover and follow-up phases. Depression and anxiety, 2013, Volume: 30, Issue:7 Topics: Adult; Aged; Antidepressive Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cross-Over Studies; Depressive Disorder, Major; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Secondary Prevention; Sertraline; Transcranial Magnetic Stimulation; Treatment Outcome	2013
Effect of sertraline on risk of falling in older adults with psychotic depression on olanzapine: results of a randomized placebo-controlled trial. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2014, Volume: 22, Issue:4 Topics: Accidental Falls; Adolescent; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Sertraline; Young Adult	2014
Heart rate variability is a trait marker of major depressive disorder: evidence from the sertraline vs. electric current therapy to treat depression clinical study. The international journal of neuropsychopharmacology, 2013, Volume: 16, Issue:9 Topics: Adult; Analysis of Variance; Antidepressive Agents; Brazil; Cardiovascular Diseases; Chi-Square Distribution; Depressive Disorder, Major; Double-Blind Method; Electric Stimulation Therapy; Female; Heart Rate; Humans; Male; Middle Aged; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Time Factors; Treatment Outcome	2013
Comparison of brain structural variables, neuropsychological factors, and treatment outcome in early-onset versus late-onset late-life depression. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2014, Volume: 22, Issue:10 Topics: Age of Onset; Aged; Antidepressive Agents; Case-Control Studies; Depressive Disorder, Major; Gray Matter; Gyrus Cinguli; Humans; Hypertrophy; Magnetic Resonance Imaging; Male; Neuroimaging; Neuropsychological Tests; Sertraline; Treatment Outcome; White Matter	2014
The influence of comorbid personality disorder on the effects of behavioural activation vs. antidepressant medication for major depressive disorder: results from a randomized trial in Iran. Behaviour research and therapy, 2013, Volume: 51, Issue:8 Topics: Adolescent; Adult; Antidepressive Agents; Behavior Therapy; Depressive Disorder, Major; Female; Humans; Iran; Male; Middle Aged; Patient Dropouts; Personality Disorders; Sertraline; Severity of Illness Index; Treatment Outcome	2013
Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder. The international journal of neuropsychopharmacology, 2013, Volume: 16, Issue:10 Topics: Adult; Antidepressive Agents; Brain; Brain Mapping; Cerebrovascular Circulation; Depressive Disorder, Major; Emotions; Facial Expression; Female; Hemodynamics; Humans; Magnetic Resonance Imaging; Male; Neurons; Neuropsychological Tests; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Outcome; Young Adult	2013
The efficacy of agomelatine in previously-treated depressed patients. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2013, Volume: 23, Issue:8 Topics: Acetamides; Adult; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Monitoring; Drug Resistance; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Psychiatric Status Rating Scales; Receptors, Melatonin; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Sertraline	2013
Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial. Trials, 2013, Jul-18, Volume: 14 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Brain; California; Citalopram; Clinical Protocols; Cognition; Cyclohexanols; Depressive Disorder, Major; Diffusion Tensor Imaging; Emotions; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; New South Wales; Predictive Value of Tests; Prospective Studies; Psychiatric Status Rating Scales; Research Design; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2013
Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder - possible role for methoxyindole pathway. PloS one, 2013, Volume: 8, Issue:7 Topics: Adolescent; Adult; Depressive Disorder, Major; Double-Blind Method; Humans; Indoles; Metabolomics; Middle Aged; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult	2013
Study protocol of the Diabetes and Depression Study (DAD): a multi-center randomized controlled trial to compare the efficacy of a diabetes-specific cognitive behavioral group therapy versus sertraline in patients with major depression and poorly controll BMC psychiatry, 2013, Aug-06, Volume: 13 Topics: Adult; Aged; Antidepressive Agents; Blood Glucose; Clinical Protocols; Cognition; Cognitive Behavioral Therapy; Depressive Disorder, Major; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Germany; Glycated Hemoglobin; Humans; Male; Middle Aged; Psychotherapy, Group; Research Design; Sertraline; Treatment Outcome; Young Adult	2013
Comparison of blinding effectiveness between sham tDCS and placebo sertraline in a 6-week major depression randomized clinical trial. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2014, Volume: 125, Issue:2 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Electric Stimulation Therapy; Female; Humans; Male; Middle Aged; Research Design; Sertraline; Treatment Outcome	2014
Antidepressant treatment of melancholia in older adults. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2014, Volume: 22, Issue:1 Topics: Aged; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Nortriptyline; Patient Dropouts; Psychiatric Status Rating Scales; Sertraline	2014
Changes in well-being and quality of life in a randomized trial comparing dynamic psychotherapy and pharmacotherapy for major depressive disorder. Journal of affective disorders, 2014, Volume: 152-154 Topics: Adaptation, Psychological; Adult; Antidepressive Agents; Depressive Disorder, Major; Female; Humans; Male; Psychotherapy, Psychodynamic; Quality of Life; Sertraline; Treatment Outcome	2014
A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures. The Journal of clinical psychiatry, 2013, Volume: 74, Issue:10 Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Monitoring; Drug Therapy, Combination; Female; Hallucinations; Humans; Male; Metabolism; Middle Aged; Olanzapine; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Sertraline; Sex Factors; Socioeconomic Factors; Treatment Outcome	2013
The impact of missing data on clinical trials: a re-analysis of a placebo controlled trial of Hypericum perforatum (St Johns wort) and sertraline in major depressive disorder. Psychopharmacology, 2014, Volume: 231, Issue:9 Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypericum; Longitudinal Studies; Male; Models, Statistical; Patient Dropouts; Phytotherapy; Plant Extracts; Psychiatric Status Rating Scales; Sensitivity and Specificity; Sertraline; Treatment Outcome	2014
Measuring treatment response in psychotic depression: the Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account. Journal of affective disorders, 2014, Volume: 160 Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Sertraline; Treatment Outcome	2014
Impact of sleep complaints and depression outcomes among participants in the standard medical intervention and long-term exercise study of exercise and pharmacotherapy for depression. The Journal of nervous and mental disease, 2014, Volume: 202, Issue:2 Topics: Adult; Depression; Depressive Disorder, Major; Exercise Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Treatment Outcome	2014
Prediction and structural equation model of sertraline treatment response in Japanese patients with major depressive disorder. Human psychopharmacology, 2013, Volume: 28, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Depressive Disorder, Major; Female; Genotype; Humans; Logistic Models; Male; Middle Aged; Models, Theoretical; Polymorphism, Genetic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tandem Repeat Sequences; Treatment Outcome; Young Adult	2013
Differential impact of anxiety symptoms and anxiety disorders on treatment outcome for psychotic depression in the STOP-PD study. Comprehensive psychiatry, 2014, Volume: 55, Issue:5 Topics: Antidepressive Agents; Antipsychotic Agents; Anxiety; Anxiety Disorders; Benzodiazepines; Depressive Disorder, Major; Female; Humans; Logistic Models; Male; Middle Aged; Olanzapine; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2014
BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: results from a factorial, randomized, sham-controlled trial. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2014, Volume: 24, Issue:7 Topics: Adult; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Sertraline; Transcranial Direct Current Stimulation; Treatment Outcome	2014
Hypothalamus-anchored resting brain network changes before and after sertraline treatment in major depression. BioMed research international, 2014, Volume: 2014 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Female; Humans; Hypothalamus; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Radiography; Sertraline	2014
Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients. Pharmacopsychiatry, 2014, Volume: 47, Issue:4-5 Topics: Activities of Daily Living; Aged; Alzheimer Disease; Antidepressive Agents; Cognition; Comorbidity; Depressive Disorder, Major; Desipramine; Double-Blind Method; Female; Humans; Male; Middle Aged; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2014
Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): an exploratory analysis. Progress in neuro-psychopharmacology & biological psychiatry, 2015, Jan-02, Volume: 56 Topics: Adult; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nerve Growth Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Transcranial Direct Current Stimulation	2015
Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial. Journal of affective disorders, 2015, Mar-15, Volume: 174 Topics: Adult; Carotenoids; Citalopram; Crocus; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Iran; Male; Middle Aged; Phytotherapy; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2015
Rational-emotive and cognitive-behavior therapy (REBT/CBT) versus pharmacotherapy versus REBT/CBT plus pharmacotherapy in the treatment of major depressive disorder in youth; a randomized clinical trial. Psychiatry research, 2015, Feb-28, Volume: 225, Issue:3 Topics: Adolescent; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Psychotherapy, Group; Psychotherapy, Rational-Emotive; Romania; Sertraline	2015
A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015, Volume: 40, Issue:6 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Cognition; Computers; Delayed-Action Preparations; Depressive Disorder, Major; Emotions; Female; Humans; Male; Middle Aged; Prognosis; Psychiatric Status Rating Scales; Psychological Tests; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2015
Impairment and distress patterns distinguishing the melancholic depression subtype: an iSPOT-D report. Journal of affective disorders, 2015, Mar-15, Volume: 174 Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Risk Factors; Sertraline; Symptom Assessment; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2015
Two Phase III randomised double-blind studies of fixed-dose TC-5214 (dexmecamylamine) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to prior antidepressant therapy. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2015, Volume: 16, Issue:7 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Mecamylamine; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Treatment Outcome; Young Adult	2015
Cognitive Behavioral Therapy Versus Sertraline in Patients With Depression and Poorly Controlled Diabetes: The Diabetes and Depression (DAD) Study: A Randomized Controlled Multicenter Trial. Diabetes care, 2015, Volume: 38, Issue:5 Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Blood Glucose; Cognitive Behavioral Therapy; Depressive Disorder, Major; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Germany; Glycated Hemoglobin; Humans; Male; Middle Aged; Sertraline; Single-Blind Method; Treatment Outcome; Young Adult	2015
Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial. The American journal of psychiatry, 2015, Aug-01, Volume: 172, Issue:8 Topics: Adult; Antidepressive Agents; Anxiety; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Outpatients; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2015
ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial. The American journal of psychiatry, 2015, Aug-01, Volume: 172, Issue:8 Topics: Adult; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Genotype; Humans; Logistic Models; Male; Middle Aged; Polymorphism, Single Nucleotide; Remission Induction; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2015
Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2015, Mar-15, Volume: 22, Issue:3 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Phytotherapy; Plant Extracts; Psychiatric Status Rating Scales; Rhodiola; Sertraline	2015
Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression. Biological psychiatry, 2016, Feb-15, Volume: 79, Issue:4 Topics: Adult; Antidepressive Agents; Australia; Citalopram; Cognition; Depressive Disorder, Major; Executive Function; Female; Humans; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Prefrontal Cortex; Prognosis; Psychiatric Status Rating Scales; Regression Analysis; Remission Induction; Sertraline; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2016
Frontal and rostral anterior cingulate (rACC) theta EEG in depression: implications for treatment outcome? European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2015, Volume: 25, Issue:8 Topics: Adult; Antidepressive Agents; Brain Mapping; Citalopram; Depressive Disorder, Major; Electroencephalography; Female; Frontal Lobe; Gyrus Cinguli; Humans; Male; Prospective Studies; Psychiatric Status Rating Scales; Remission Induction; Sertraline; Severity of Illness Index; Theta Rhythm; Venlafaxine Hydrochloride	2015
The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD. Clinical pharmacokinetics, 2015, Volume: 54, Issue:11 Topics: Adult; Aged; Benzodiazepines; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Models, Biological; Olanzapine; Psychotic Disorders; Sertraline; Sex Factors	2015
Physical exercise for late-life major depression. The British journal of psychiatry : the journal of mental science, 2015, Volume: 207, Issue:3 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder, Major; Exercise; Exercise Therapy; Female; Humans; Male; Medication Adherence; Remission Induction; Sertraline; Treatment Outcome	2015
Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: Results from the SELECT-TDCS trial. Journal of affective disorders, 2015, Oct-01, Volume: 185 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Prospective Studies; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Sertraline; Transcranial Direct Current Stimulation; Treatment Outcome	2015
Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2015, Volume: 25, Issue:11 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Brain; Brain Mapping; Citalopram; Depressive Disorder, Major; Electroencephalography; Evoked Potentials; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis; Prospective Studies; Sertraline; Sex Characteristics; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2015
Strategic use of new generation antidepressants for depression: SUN(^_^) D protocol update and statistical analysis plan. Trials, 2015, Oct-14, Volume: 16 Topics: Antidepressive Agents, Tricyclic; Clinical Protocols; Data Interpretation, Statistical; Depressive Disorder, Major; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Humans; Japan; Mianserin; Mirtazapine; Patient Dropouts; Psychiatric Status Rating Scales; Research Design; Sample Size; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Outcome	2015
A study of sertraline in dialysis (ASSertID): a protocol for a pilot randomised controlled trial of drug treatment for depression in patients undergoing haemodialysis. BMC nephrology, 2015, Oct-26, Volume: 16 Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Humans; Kidney Failure, Chronic; Pilot Projects; Renal Dialysis; Research Design; Sertraline	2015
Relationship Between Cerebrovascular Risk, Cognition, and Treatment Outcome in Late-Life Psychotic Depression. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2015, Volume: 23, Issue:12 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Cerebrovascular Disorders; Cognition; Cognition Disorders; Depressive Disorder, Major; Double-Blind Method; Executive Function; Humans; Mental Processes; Middle Aged; Neuropsychological Tests; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Reaction Time; Risk; Sertraline; Severity of Illness Index; Stroop Test; Treatment Outcome; Young Adult	2015
Rationale and design of A Trial of Sertraline vs. Cognitive Behavioral Therapy for End-stage Renal Disease Patients with Depression (ASCEND). Contemporary clinical trials, 2016, Volume: 47 Topics: Antidepressive Agents; Cognitive Behavioral Therapy; Comorbidity; Depression; Depressive Disorder, Major; Dysthymic Disorder; Humans; Kidney Failure, Chronic; Renal Dialysis; Sertraline; Treatment Outcome	2016
Effects of Exercise and Sertraline on Measures of Coronary Heart Disease Risk in Patients With Major Depression: Results From the SMILE-II Randomized Clinical Trial. Psychosomatic medicine, 2016, Volume: 78, Issue:5 Topics: Adult; Combined Modality Therapy; Coronary Disease; Depressive Disorder, Major; Exercise Therapy; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline	2016
Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design. Journal of psychiatric research, 2016, Volume: 78 Topics: Adult; Antidepressive Agents; Biomarkers; Brain; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Humans; Magnetic Resonance Imaging; Male; Patient Selection; Precision Medicine; Psychiatric Status Rating Scales; Quinazolines; Research Design; Sertraline; Treatment Outcome	2016
Comparing the Effects of Sertraline with Duloxetine for Depression Severity and Symptoms: A Double-Blind, Randomized Controlled Trial. Clinical drug investigation, 2016, Volume: 36, Issue:7 Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychomotor Performance; Sertraline; Sexual Dysfunction, Physiological; Suicidal Ideation; Treatment Outcome	2016
Prediction of nonremission to antidepressant therapy using diffusion tensor imaging. The Journal of clinical psychiatry, 2016, Volume: 77, Issue:4 Topics: Adult; Antidepressive Agents; Brain; Citalopram; Delayed-Action Preparations; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Diffusion Magnetic Resonance Imaging; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nerve Net; Predictive Value of Tests; Psychiatric Status Rating Scales; Sertraline; Venlafaxine Hydrochloride; White Matter; Young Adult	2016
Cognitive effects of transcranial direct current stimulation in depression: Results from the SELECT-TDCS trial and insights for further clinical trials. Journal of affective disorders, 2016, Sep-15, Volume: 202 Topics: Adult; Aged; Cognition; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Problem Solving; Sertraline; Transcranial Direct Current Stimulation; Treatment Outcome; Young Adult	2016
Nepeta menthoides Boiss. & Buhse freeze-dried aqueous extract versus sertraline in the treatment of major depression: A double blind randomized controlled trial. Complementary therapies in medicine, 2016, Volume: 26 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Medicine, Arabic; Middle Aged; Nepeta; Plant Extracts; Sertraline	2016
Influence of ACE gene on differential response to sertraline versus fluoxetine in patients with major depression: a randomized controlled trial. European journal of clinical pharmacology, 2016, Volume: 72, Issue:9 Topics: Adolescent; Adult; Aged; Alleles; Antidepressive Agents; Depressive Disorder, Major; Female; Fluoxetine; Genotype; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Sertraline; Young Adult	2016
Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies. Journal of affective disorders, 2016, Volume: 206 Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Least-Squares Analysis; Lisdexamfetamine Dimesylate; Male; Middle Aged; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2016
Cost-Effective Drug Switch Options After Unsuccessful Treatment With an SSRI for Depression. Psychiatric services (Washington, D.C.), 2017, 01-01, Volume: 68, Issue:1 Topics: Adult; Bupropion; Citalopram; Cost-Benefit Analysis; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride	2017
Physical Exercise for Late-Life Depression: Effects on Heart Rate Variability. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2016, Volume: 24, Issue:11 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Autonomic Nervous System; Depressive Disorder, Major; Exercise; Exercise Therapy; Female; Heart Rate; Humans; Late Onset Disorders; Male; Sertraline; Single-Blind Method	2016
Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants. Journal of affective disorders, 2017, Jan-15, Volume: 208 Topics: Adult; Antidepressive Agents; Aripiprazole; Central Nervous System Stimulants; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Sertraline; Treatment Outcome	2017
Are Patients with Childhood Onset of Insomnia and Depression More Difficult to Treat Than Are Those with Adult Onsets of These Disorders? A Report from the TRIAD Study. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2017, Feb-15, Volume: 13, Issue:2 Topics: Adult; Age of Onset; Antidepressive Agents; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Desvenlafaxine Succinate; Humans; Middle Aged; Sertraline; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Treatment Outcome; United States	2017
Physical Exercise for Late-Life Depression: Customizing an Intervention for Primary Care. Journal of the American Geriatrics Society, 2017, Volume: 65, Issue:2 Topics: Age Factors; Aged; Antidepressive Agents; Anxiety; Attitude of Health Personnel; Combined Modality Therapy; Depressive Disorder, Major; Exercise; Female; Humans; Male; Oxygen Consumption; Physicians, Primary Care; Polypharmacy; Primary Health Care; Psychomotor Performance; Remission Induction; Sertraline; Severity of Illness Index; Single-Blind Method	2017
Sertraline Versus Placebo in Patients with Major Depressive Disorder Undergoing Hemodialysis: A Randomized, Controlled Feasibility Trial. Clinical journal of the American Society of Nephrology : CJASN, 2017, 02-07, Volume: 12, Issue:2 Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Feasibility Studies; Female; Humans; Male; Medication Adherence; Middle Aged; Patient Dropouts; Psychiatric Status Rating Scales; Renal Dialysis; Renal Insufficiency, Chronic; Sertraline; Treatment Outcome	2017
Improvement in Depression is Associated with Improvement in Cognition in Late-Life Psychotic Depression. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2017, Volume: 25, Issue:6 Topics: Aged; Aged, 80 and over; Aging; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Cognition; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Humans; Late Onset Disorders; Middle Aged; Olanzapine; Psychotic Disorders; Sertraline; Treatment Outcome	2017
Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. Journal of psychiatric research, 2009, Volume: 43, Issue:3 Topics: Adult; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Cyclohexanols; Depressive Disorder, Major; Enzyme-Linked Immunosorbent Assay; Female; Humans; Linear Models; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2009
Exercise fails to improve neurocognition in depressed middle-aged and older adults. Medicine and science in sports and exercise, 2008, Volume: 40, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antidepressive Agents; Cognition; Cognition Disorders; Data Interpretation, Statistical; Depressive Disorder, Major; Exercise; Exercise Therapy; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Physical Fitness; Psychometrics; Sedentary Behavior; Sertraline	2008
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. Archives of general psychiatry, 2008, Volume: 65, Issue:8 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Humans; Middle Aged; Personality Inventory; Primary Health Care; Prognosis; Retreatment; Secondary Prevention; Sertraline; Venlafaxine Hydrochloride	2008
Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2008, Volume: 18, Issue:11 Topics: Acute Disease; Adolescent; Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Hypericum; Male; Middle Aged; Outpatients; Phytotherapy; Plant Extracts; Psychiatric Status Rating Scales; Sample Size; Secondary Prevention; Sertraline; Treatment Outcome; Young Adult	2008
Maintenance study for adolescent depression. Journal of child and adolescent psychopharmacology, 2008, Volume: 18, Issue:4 Topics: Adolescent; Adult; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Sertraline; Survival Analysis; Time Factors; Treatment Outcome	2008
The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:4 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Male; Middle Aged; Piperazines; Quinolones; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult	2010
[A comparative study of efficacy and safety of torin and zoloft]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2008, Volume: 108, Issue:8 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Sertraline	2008
Smoking behavior postmyocardial infarction among ENRICHD trial participants: cognitive behavior therapy intervention for depression and low perceived social support compared with care as usual. Psychosomatic medicine, 2008, Volume: 70, Issue:8 Topics: Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Depressive Disorder, Major; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Personality Inventory; Sertraline; Sick Role; Smoking; Smoking Cessation; Social Support	2008
Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy. Journal of affective disorders, 2009, Volume: 114, Issue:1-3 Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Inpatients; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotherapy; Sertraline; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult	2009
Pharmacokinetics of sertraline across pregnancy and postpartum. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:6 Topics: 1-Naphthylamine; Adult; Body Weight; Depressive Disorder, Major; Female; Humans; Longitudinal Studies; Postpartum Period; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult	2008
High cortisol awakening response is associated with an impairment of the effect of bright light therapy. Acta psychiatrica Scandinavica, 2009, Volume: 120, Issue:3 Topics: Depressive Disorder, Major; Double-Blind Method; Female; Humans; Hydrocortisone; Male; Middle Aged; Phototherapy; Predictive Value of Tests; Psychometrics; Saliva; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Failure; Wakefulness	2009
Sexual function in postpartum women treated for depression: results from a randomized trial of nortriptyline versus sertraline. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:3 Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Arousal; Depression, Postpartum; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Humans; Libido; Multicenter Studies as Topic; Nortriptyline; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Surveys and Questionnaires; Young Adult	2009
Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression. Journal of affective disorders, 2010, Volume: 120, Issue:1-3 Topics: Adult; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Predictive Value of Tests; Prospective Studies; Sertraline; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Treatment Outcome	2010
A pooled analysis of suicidality in double-blind, placebo-controlled studies of sertraline in adults. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:5 Topics: Adult; Age Factors; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Incidence; Life Change Events; Male; Prevalence; Sertraline; Suicide, Attempted; Young Adult	2009
Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder. Neuropsychobiology, 2009, Volume: 59, Issue:4 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Atomoxetine Hydrochloride; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Odds Ratio; Propylamines; Recurrence; Sertraline; Tachyphylaxis; Treatment Outcome	2009
Effects of selective serotonin reuptake inhibitors on thyroid function in depressed patients with primary hypothyroidism or normal thyroid function. Thyroid : official journal of the American Thyroid Association, 2009, Volume: 19, Issue:7 Topics: Adult; Aged; Autoantibodies; Depressive Disorder, Major; Fluoxetine; Humans; Hypothyroidism; Iodide Peroxidase; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine	2009
A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Archives of general psychiatry, 2009, Volume: 66, Issue:8 Topics: Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Humans; Olanzapine; Placebos; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2009
Neuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal women. Archives of women's mental health, 2010, Volume: 13, Issue:1 Topics: Brain; Dehydroepiandrosterone; Depressive Disorder, Major; Desoxycorticosterone; Estrogens; Female; Humans; Middle Aged; Postmenopause; Pregnanolone; Selective Serotonin Reuptake Inhibitors; Sertraline	2010
Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Alleles; Brain-Derived Neurotrophic Factor; Depressive Disorder, Major; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Polymorphism, Genetic; Promoter Regions, Genetic; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Severity of Illness Index; Treatment Outcome; Young Adult	2010
Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA, 2009, Oct-21, Volume: 302, Issue:15 Topics: Antidepressive Agents; Comorbidity; Coronary Disease; Depressive Disorder, Major; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Drug Synergism; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Humans; Male; Middle Aged; Sertraline	2009
Pharmacogenetics studies in STARD: strengths, limitations, and results. Psychiatric services (Washington, D.C.), 2009, Volume: 60, Issue:11* Topics: Adult; Biomarkers; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Humans; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Receptors, Kainic Acid; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Sertraline; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride	2009
Combination of pharmacotherapy with electroconvulsive therapy in prevention of depressive relapse: a pilot controlled trial. The journal of ECT, 2010, Volume: 26, Issue:2 Topics: Adolescent; Adult; Age of Onset; Aged; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Recurrence; Sertraline; Treatment Outcome	2010
Collaborative care for depressed patients with chronic medical conditions: a randomized trial in Puerto Rico. Psychiatric services (Washington, D.C.), 2010, Volume: 61, Issue:2 Topics: Adult; Aged; Antidepressive Agents; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Cooperative Behavior; Depressive Disorder, Major; Female; Humans; Interprofessional Relations; Male; Managed Care Programs; Middle Aged; Patient Care Team; Puerto Rico; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Adjustment; Treatment Outcome	2010
Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline. The Journal of clinical psychiatry, 2010, Volume: 71, Issue:2 Topics: Acetamides; Actigraphy; Adolescent; Adult; Antidepressive Agents; Anxiety; Circadian Rhythm; Depression; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Middle Aged; Motor Activity; Psychiatric Status Rating Scales; Rest; Sertraline; Severity of Illness Index; Sleep; Treatment Outcome	2010
Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Archives of general psychiatry, 2010, Volume: 67, Issue:3 Topics: Age of Onset; Aged; Brain; Cerebrovascular Disorders; Cognition Disorders; Depressive Disorder, Major; Executive Function; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Proportional Hazards Models; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome	2010
A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. The American journal of psychiatry, 2010, Volume: 167, Issue:6 Topics: Adult; Alcoholism; Comorbidity; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Naltrexone; Selective Serotonin Reuptake Inhibitors; Sertraline	2010
Site versus centralized raters in a clinical depression trial: impact on patient selection and placebo response. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:2 Topics: Cross-Sectional Studies; Depressive Disorder, Major; Female; Humans; Male; Observer Variation; Patient Selection; Placebo Effect; Psychiatric Status Rating Scales; Remote Consultation; Sertraline; Single-Blind Method; Treatment Outcome	2010
No effect of adding brief dynamic therapy to pharmacotherapy in the treatment of obsessive-compulsive disorder with concurrent major depression. Psychotherapy and psychosomatics, 2010, Volume: 79, Issue:5 Topics: Adult; Combined Modality Therapy; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Psychotherapy, Brief; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2010
Depressive mood, suicide ideation and anxiety in smokers who do and smokers who do not manage to stop smoking after a target quit day. Addiction (Abingdon, England), 2010, Volume: 105, Issue:12 Topics: Adolescent; Adult; Aged; Anxiety; Depression; Depressive Disorder, Major; Female; Humans; Linear Models; Male; Medical Records; Middle Aged; Patient Acceptance of Health Care; Placebos; Psychiatric Status Rating Scales; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Smoking; Smoking Cessation; Suicidal Ideation; Young Adult	2010
Sertraline vs. ELectrical Current Therapy for Treating Depression Clinical Trial--SELECT TDCS: design, rationale and objectives. Contemporary clinical trials, 2011, Volume: 32, Issue:1 Topics: Antidepressive Agents; Cerebral Cortex; Clinical Protocols; Combined Modality Therapy; Depressive Disorder, Major; Double-Blind Method; Electric Stimulation Therapy; Humans; Research Design; Sertraline; Treatment Outcome	2011
Partial compliance as determined from plasma levels of sertraline and its metabolite in depressed patients in primary care. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder, Major; Drug Monitoring; Female; Humans; Male; Medication Adherence; Middle Aged; Primary Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult	2010
International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. Trials, 2011, Jan-05, Volume: 12 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Australia; Citalopram; Cognition; Cyclohexanols; Decision Support Techniques; Depressive Disorder, Major; Electroencephalography; Emotions; Europe; Female; Humans; Male; Middle Aged; Neuropsychological Tests; New Zealand; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Behavior; Time Factors; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult	2011
Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response. Molecular psychiatry, 2012, Volume: 17, Issue:2 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Female; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Predictive Value of Tests; Psychiatric Status Rating Scales; Sertraline; Statistics as Topic; Telomerase	2012
Topiramate augmentation in patients with resistant major depressive disorder: a double-blind placebo-controlled clinical trial. Progress in neuro-psychopharmacology & biological psychiatry, 2011, Jun-01, Volume: 35, Issue:4 Topics: Adult; Citalopram; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Fructose; Humans; Male; Neuroprotective Agents; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Topiramate	2011
Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial. Journal of psychiatric research, 2011, Volume: 45, Issue:7 Topics: Adult; Affective Disorders, Psychotic; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Olanzapine; Retreatment; Sertraline	2011
Strategic use of new generation antidepressants for depression: SUN(^_^)D study protocol. Trials, 2011, May-11, Volume: 12 Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cluster Analysis; Depressive Disorder, Major; Drug Administration Schedule; Drug Substitution; Female; Humans; Japan; Male; Mianserin; Middle Aged; Mirtazapine; Patient Selection; Psychiatric Status Rating Scales; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Time Factors; Treatment Outcome	2011
Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression. Journal of psychosomatic research, 2011, Volume: 71, Issue:1 Topics: Adult; Aged; Antidepressive Agents; Biomarkers; C-Reactive Protein; Coronary Disease; Depressive Disorder, Major; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Treatment Outcome; Tumor Necrosis Factor-alpha	2011
Faster onset of antidepressant effects of citalopram compared with sertraline in drug-naïve first-episode major depressive disorder in a Chinese population: a 6-week double-blind, randomized comparative study. Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:5 Topics: Adult; China; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Outcome; Young Adult	2011
Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study. Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:5 Topics: Adolescent; Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Sertraline; Treatment Outcome; Young Adult	2011
Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trial. Progress in neuro-psychopharmacology & biological psychiatry, 2011, Dec-01, Volume: 35, Issue:8 Topics: Adult; Aged; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Drug Substitution; Female; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Sertraline; Time Factors; Treatment Outcome	2011
Obstructive sleep apnea/hypopnea syndrome and poor response to sertraline in patients with coronary heart disease. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:1 Topics: Antidepressive Agents; Coronary Disease; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Fatty Acids, Omega-3; Female; Heart Rate; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Sleep Apnea, Obstructive	2012
The effects of sertraline on psychopathic traits. International clinical psychopharmacology, 2011, Volume: 26, Issue:6 Topics: Adult; Antidepressive Agents; Antisocial Personality Disorder; Comorbidity; Depressive Disorder, Major; Double-Blind Method; Female; Hormones; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Triiodothyronine	2011
Plasma omega-3 polyunsaturated fatty acids and survival in patients with chronic heart failure and major depressive disorder. Journal of cardiovascular translational research, 2012, Volume: 5, Issue:1 Topics: Aged; Antidepressive Agents; Biomarkers; Cause of Death; Chi-Square Distribution; Chronic Disease; Depressive Disorder, Major; Disease-Free Survival; Down-Regulation; Fatty Acids, Omega-3; Female; Flame Ionization; Heart Failure; Humans; Male; Middle Aged; North Carolina; Prognosis; Proportional Hazards Models; Sertraline; Survival Analysis; Survival Rate; Time Factors	2012
Association between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the Hypericum Depression Trial Study Group. The Journal of clinical psychiatry, 2011, Volume: 72, Issue:12 Topics: Adult; Analysis of Variance; Depressive Disorder, Major; Humans; Hypericum; Middle Aged; Patients; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2011
Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:1 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Ethnicity; Female; Humans; Male; Middle Aged; Patient Dropouts; Psychiatric Status Rating Scales; Psychotherapy, Brief; Sertraline; Sex Characteristics; Venlafaxine Hydrochloride	2012
Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept. Translational psychiatry, 2011, Volume: 1 Topics: Adult; Chromatography, Liquid; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Least-Squares Analysis; Male; Metabolic Networks and Pathways; Metabolomics; Middle Aged; Outpatients; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline	2011
Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STARD. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:1* Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Female; Humans; Likelihood Functions; Male; Middle Aged; Personality Inventory; Psychometrics; Quality of Life; Sertraline; United States; Venlafaxine Hydrochloride; Young Adult	2012
Sertraline treatment of patients with major depressive disorder who failed initial treatment with paroxetine or fluvoxamine. Progress in neuro-psychopharmacology & biological psychiatry, 2012, Aug-07, Volume: 38, Issue:2 Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug Administration Schedule; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Sertraline; Severity of Illness Index; Treatment Outcome	2012
Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study. Journal of affective disorders, 2012, Dec-10, Volume: 141, Issue:2-3 Topics: Adult; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Biomarkers; Celecoxib; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Interleukin-6; Male; Middle Aged; Outcome Assessment, Health Care; Pyrazoles; Sertraline; Sulfonamides	2012
St John's wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT. Pharmacopsychiatry, 2012, Volume: 45, Issue:7 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Hypericum; Male; Middle Aged; Placebos; Plant Extracts; Psychiatric Status Rating Scales; Sertraline	2012
The first 100 patients in the SUN(^_^)D trial (strategic use of new generation antidepressants for depression): examination of feasibility and adherence during the pilot phase. Trials, 2012, Jun-08, Volume: 13 Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Drug Substitution; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Informed Consent; Japan; Male; Medication Adherence; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Time Factors; Treatment Outcome	2012
Effect of terazosin on sweating in patients with major depressive disorder receiving sertraline: a randomized controlled trial. International journal of psychiatry in clinical practice, 2013, Volume: 17, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Prazosin; Selective Serotonin Reuptake Inhibitors; Sertraline; Sweating; Treatment Outcome	2013
The combination of triiodothyronine (T3) and sertraline is not superior to sertraline monotherapy in the treatment of major depressive disorder. Journal of psychiatric research, 2012, Volume: 46, Issue:11 Topics: Adolescent; Adult; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Sertraline; Severity of Illness Index; Treatment Outcome; Triiodothyronine; Young Adult	2012
Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo. Translational psychiatry, 2013, Jan-22, Volume: 3 Topics: Adult; Depressive Disorder, Major; Double-Blind Method; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Metabolome; Middle Aged; Placebo Effect; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Outcome	2013
The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. JAMA psychiatry, 2013, Volume: 70, Issue:4 Topics: Adult; Combined Modality Therapy; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Transcranial Magnetic Stimulation; Treatment Outcome	2013
Behavioural activation v. antidepressant medication for treating depression in Iran: randomised trial. The British journal of psychiatry : the journal of mental science, 2013, Volume: 202, Issue:3 Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Antidepressive Agents; Behavior Therapy; Depressive Disorder, Major; Female; Humans; Intention to Treat Analysis; Iran; Male; Middle Aged; Multilevel Analysis; Outcome Assessment, Health Care; Patient Dropouts; Psychiatric Status Rating Scales; Recurrence; Sertraline; Severity of Illness Index; Young Adult	2013
Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA, 2002, Aug-14, Volume: 288, Issue:6 Topics: Angina, Unstable; Depressive Disorder, Major; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2002
Sertraline is more effective than imipramine in the treatment of non-melancholic depression: results from a multicentre, randomized study. Progress in neuro-psychopharmacology & biological psychiatry, 2003, Volume: 27, Issue:3 Topics: Adolescent; Adult; Aged; Analysis of Variance; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Sertraline	2003
Effect of increasing the dose and duration of sertraline trial in the treatment of depressed nursing home residents. Journal of geriatric psychiatry and neurology, 2003, Volume: 16, Issue:2 Topics: Acute Disease; Aged; Aged, 80 and over; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Nursing Homes; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Surveys and Questionnaires	2003
An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. The American journal of psychiatry, 2003, Volume: 160, Issue:7 Topics: Age Factors; Aged; Aged, 80 and over; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome	2003
Long-term efficacy and therapeutic drug monitoring of sertraline in major depression. Human psychopharmacology, 2003, Volume: 18, Issue:5 Topics: Adult; Aged; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors	2003
Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA, 2003, Aug-27, Volume: 290, Issue:8 Topics: Adolescent; Antidepressive Agents; Child; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Psychological Tests; Selective Serotonin Reuptake Inhibitors; Sertraline	2003
The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder. Psychopharmacology, 2004, Volume: 174, Issue:4 Topics: Aged; Alleles; Analysis of Variance; Case-Control Studies; Depressive Disorder, Major; Double-Blind Method; Female; Genotype; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Polymorphism, Genetic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Severity of Illness Index; Time Factors; Treatment Outcome	2004
Brain lesion volume and neuropsychological function predict efficacy of treatment for depression in multiple sclerosis. Journal of consulting and clinical psychology, 2003, Volume: 71, Issue:6 Topics: Adult; Antidepressive Agents; Brain; Cerebral Ventricles; Cognitive Behavioral Therapy; Depressive Disorder, Major; Dominance, Cerebral; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Neurologic Examination; Neuropsychological Tests; Outcome and Process Assessment, Health Care; Personality Inventory; Prognosis; Psychometrics; Psychotherapy, Group; Reproducibility of Results; Sertraline; Temporal Lobe	2003
Effects of sertraline on sleep architecture in patients with depression. Journal of clinical psychopharmacology, 2003, Volume: 23, Issue:6 Topics: Adult; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Humans; Male; Middle Aged; Polysomnography; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep	2003
Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial. Journal of clinical psychopharmacology, 2003, Volume: 23, Issue:6 Topics: Adult; Alcoholics Anonymous; Alcoholism; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Double-Blind Method; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2003
Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder. The American journal of psychiatry, 2004, Volume: 161, Issue:2 Topics: Adolescent; Adult; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Female; Humans; Middle Aged; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Surveys and Questionnaires	2004
Patient predictors of response to treatment of depression in Alzheimer's disease: the DIADS study. International journal of geriatric psychiatry, 2004, Volume: 19, Issue:2 Topics: Aged; Aggression; Alzheimer Disease; Antidepressive Agents; Caregivers; Depressive Disorder, Major; Female; Geriatric Assessment; Humans; Male; Neuropsychological Tests; Psychiatric Status Rating Scales; Psychomotor Agitation; Sertraline; Single-Blind Method; Treatment Outcome	2004
Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Aged; Connecticut; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Hospitals, Veterans; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Pindolol; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Veterans	2004
Effects of serotonergic and noradrenergic antidepressants on auditory startle response in patients with major depression. Psychopharmacology, 2004, Volume: 175, Issue:4 Topics: Acoustic Stimulation; Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Electrodes; Female; Habituation, Psychophysiologic; Humans; Male; Middle Aged; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Sertraline	2004
Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression. Human psychopharmacology, 2004, Volume: 19, Issue:5 Topics: Adolescent; Adult; Aged; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Monitoring; Female; Half-Life; Humans; Male; Middle Aged; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors	2004
The influence of 4-week treatment with sertraline on the combined T3/TRH test in depressed patients. European archives of psychiatry and clinical neuroscience, 2005, Volume: 255, Issue:5 Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Depressive Disorder, Major; Electrochemistry; Female; Humans; Immunoassay; Male; Middle Aged; Prolactin; Psychiatric Status Rating Scales; Sertraline; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors; Triiodothyronine	2005
Weight changes in postpartum women with remitted depression. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:3 Topics: Adolescent; Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depression, Postpartum; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Middle Aged; Nortriptyline; Placebos; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Weight Loss	2005
Adjunctive bright light in non-seasonal major depression: results from patient-reported symptom and well-being scales. Acta psychiatrica Scandinavica, 2005, Volume: 111, Issue:6 Topics: Age of Onset; Combined Modality Therapy; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Light; Male; Middle Aged; Patient Satisfaction; Phototherapy; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2005
Investigation of consumer satisfaction with cognitive-behaviour therapy and sertraline in the treatment of adolescent depression. The Australian and New Zealand journal of psychiatry, 2005, Volume: 39, Issue:6 Topics: Adolescent; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Consumer Behavior; Depressive Disorder, Major; Humans; Parents; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires	2005
Treatment of late-life depression complicated by alcohol dependence. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2005, Volume: 13, Issue:6 Topics: Age of Onset; Aged; Alcoholism; Antidepressive Agents; Depressive Disorder, Major; Empathy; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Sertraline; Social Support	2005
Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:6 Topics: Aged; Aged, 80 and over; Ambulatory Care; Depressive Disorder; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stroke; Treatment Outcome	2005
Partial sleep deprivation therapy combined with sertraline induces more rapid improvements in quality of life items in major depressive disorder. Journal of affective disorders, 2005, Volume: 88, Issue:1 Topics: Adult; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Personality Inventory; Quality of Life; Sertraline; Sleep Deprivation; Treatment Outcome	2005
Efficacy, predictors of therapy response, and safety of sertraline in routine clinical practice: prospective, open-label, non-interventional postmarketing surveillance study in 1878 patients. Journal of affective disorders, 2005, Volume: 87, Issue:2-3 Topics: Adult; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Product Surveillance, Postmarketing; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Treatment Outcome	2005
Partial sleep deprivation therapy combined with sertraline affects subjective sleep quality in major depressive disorder. Sleep medicine, 2005, Volume: 6, Issue:6 Topics: Adult; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Sertraline; Sleep; Sleep Deprivation; Treatment Outcome	2005
Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial. Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:5 Topics: Aged; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Double-Blind Method; Female; Fluvoxamine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline	2005
Caregiver assessment of patients' depression in Alzheimer disease: longitudinal analysis in a drug treatment study. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2005, Volume: 13, Issue:9 Topics: Affect; Aged; Alzheimer Disease; Antidepressive Agents; Bias; Caregivers; Comorbidity; Cost of Illness; Depressive Disorder, Major; Double-Blind Method; Humans; Longitudinal Studies; Outcome Assessment, Health Care; Personality Assessment; Psychometrics; Reproducibility of Results; Sertraline	2005
Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:10 Topics: Adult; Ambulatory Care; Blood Pressure; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Health Status; Humans; Male; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Substance Withdrawal Syndrome; Treatment Outcome; Venlafaxine Hydrochloride	2005
A placebo-controlled, randomized withdrawal study of sertraline for major depressive disorder in Japan. International clinical psychopharmacology, 2006, Volume: 21, Issue:1 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Japan; Male; Middle Aged; Secondary Prevention; Sertraline; Time Factors	2006
[Combination therapy using sertraline with sleep deprivation and light therapy compared to sertraline monotherapy for major depressive disorder]. Turk psikiyatri dergisi = Turkish journal of psychiatry, 2005,Winter, Volume: 16, Issue:4 Topics: Adult; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Phototherapy; Psychometrics; Sertraline; Sleep Deprivation; Treatment Outcome	2005
Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:12 Topics: Adult; Citalopram; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Transcranial Magnetic Stimulation; Treatment Outcome; Venlafaxine Hydrochloride	2005
Sertraline treatment of co-occurring alcohol dependence and major depression. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:1 Topics: Adult; Alcoholism; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2006
Response of emotional unawareness after stroke to antidepressant treatment. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2006, Volume: 14, Issue:3 Topics: Activities of Daily Living; Affective Symptoms; Aged; Agnosia; Antidepressive Agents; Awareness; Cognition; Depressive Disorder, Major; Emotions; Fluoxetine; Follow-Up Studies; Humans; Internal-External Control; Mental Status Schedule; Personality Inventory; Sertraline; Stroke	2006
Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Archives of general psychiatry, 2006, Volume: 63, Issue:3 Topics: Acute Disease; Ambulatory Care; Comorbidity; Coronary Disease; Depressive Disorder, Major; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Multivariate Analysis; Outpatient Clinics, Hospital; Placebos; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Time Factors; Treatment Outcome	2006
Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study. CNS spectrums, 2006, Volume: 11, Issue:2 Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Central Nervous System Stimulants; Depressive Disorder, Major; Disorders of Excessive Somnolence; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Fatigue; Female; Humans; Male; Middle Aged; Modafinil; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	2006
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. The New England journal of medicine, 2006, Mar-23, Volume: 354, Issue:12 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Male; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Failure; Venlafaxine Hydrochloride	2006
Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study. Journal of neurology, 2006, Volume: 253, Issue:5 Topics: Aged; Analysis of Variance; Antidepressive Agents; Antiparkinson Agents; Benzothiazoles; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Psychiatric Status Rating Scales; Sertraline; Single-Blind Method	2006
Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Archives of general psychiatry, 2006, Volume: 63, Issue:5 Topics: Age of Onset; Comorbidity; Depressive Disorder, Major; Diabetes Mellitus; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Outcome	2006
The lack of sustained effect of bright light, after discontinuation, in non-seasonal major depression. Psychological medicine, 2006, Volume: 36, Issue:9 Topics: Adult; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Phototherapy; Psychometrics; Seasons; Sertraline; Surveys and Questionnaires; Time Factors	2006
Cost of depression: effect of adherence and treatment response. European psychiatry : the journal of the Association of European Psychiatrists, 2006, Volume: 21, Issue:6 Topics: Antidepressive Agents; Demography; Depressive Disorder, Major; Drug Monitoring; Female; Follow-Up Studies; Health Care Costs; Humans; Male; Mental Health Services; Middle Aged; Patient Compliance; Primary Health Care; Quality of Life; Sertraline; Social Environment; Surveys and Questionnaires	2006
A comparison of the efficacy and tolerability of reboxetine and sertraline versus venlafaxine in major depressive disorder: a randomized, open-labeled clinical trial. Progress in neuro-psychopharmacology & biological psychiatry, 2006, Sep-30, Volume: 30, Issue:7 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Cyclohexanols; Depressive Disorder, Major; Drug Evaluation; Drug Interactions; Female; Humans; Male; Middle Aged; Morpholines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Venlafaxine Hydrochloride	2006
A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder. Current medical research and opinion, 2006, Volume: 22, Issue:9 Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Sertraline; Trazodone	2006
A comparison of cognitive-behavioral therapy, sertraline, and their combination for adolescent depression. Journal of the American Academy of Child and Adolescent Psychiatry, 2006, Volume: 45, Issue:10 Topics: Adolescent; Antidepressive Agents; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Follow-Up Studies; Humans; Male; Sertraline	2006
Sertraline in children and adolescents with major depressive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 2006, Volume: 45, Issue:10 Topics: Adolescent; Antidepressive Agents; Child; Depressive Disorder, Major; Female; Humans; Male; Prospective Studies; Sertraline	2006
A delusion assessment scale for psychotic major depression: Reliability, validity, and utility. Biological psychiatry, 2006, Dec-15, Volume: 60, Issue:12 Topics: Adult; Affect; Antipsychotic Agents; Benzodiazepines; Delusions; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Observer Variation; Olanzapine; Principal Component Analysis; Psychiatric Status Rating Scales; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline	2006
Serum monitoring of antipsychotic drug levels during concomitant administration of sertraline and antipsychotic medication. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2006, Volume: 51, Issue:11 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Comorbidity; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Monitoring; Humans; Middle Aged; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline	2006
A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder. The Journal of clinical psychiatry, 2006, Volume: 67, Issue:11 Topics: Adult; Antidepressive Agents; Chi-Square Distribution; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2006
Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy. The Journal of clinical psychiatry, 2006, Volume: 67, Issue:11 Topics: Adult; Biomarkers; CD40 Ligand; Citalopram; Depressive Disorder, Major; Factor VIIa; Female; Humans; Inflammation; Interleukin-1beta; Male; P-Selectin; Pilot Projects; Selective Serotonin Reuptake Inhibitors; Sertraline; Tumor Necrosis Factor-alpha; Up-Regulation	2006
Treatment preferences affect the therapeutic alliance: implications for randomized controlled trials. Journal of consulting and clinical psychology, 2007, Volume: 75, Issue:1 Topics: Adult; Choice Behavior; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index	2007
Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:4 Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Female; Humans; Male; Middle Aged; Propylamines; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index	2007
An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results. The American journal of psychiatry, 2007, Volume: 164, Issue:5 Topics: Adult; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cohort Studies; Combined Modality Therapy; Depressive Disorder, Major; Female; Follow-Up Studies; Hospitalization; Humans; Interpersonal Relations; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Psychotherapy; Psychotherapy, Group; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome	2007
Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography. Psychopharmacology, 2007, Volume: 193, Issue:4 Topics: Adult; Antidepressive Agents; Citalopram; Corpus Striatum; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Venlafaxine Hydrochloride	2007
Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial. Archives of general psychiatry, 2007, Volume: 64, Issue:6 Topics: Adult; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Thyroid Function Tests; Thyrotropin; Treatment Outcome; Triiodothyronine	2007
Response inhibition predicts poor antidepressant treatment response in very old depressed patients. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2007, Volume: 15, Issue:7 Topics: Age of Onset; Aged; Antidepressive Agents; Cardiovascular Diseases; Cognition Disorders; Depressive Disorder, Major; Drug Resistance; Female; Humans; Male; Sertraline; Single-Blind Method; Treatment Outcome	2007
Suicidal thinking and behavior during treatment with sertraline in late-life depression. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2007, Volume: 15, Issue:7 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Sertraline; Severity of Illness Index; Suicide, Attempted; Surveys and Questionnaires; Thinking	2007
Acute worsening of chronic depression during a double-blind, randomized clinical trial of antidepressant efficacy: differences by sex and menopausal status. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:6 Topics: Adult; Cross-Over Studies; Depressive Disorder, Major; Disease Progression; Double-Blind Method; Dysthymic Disorder; Female; Humans; Imipramine; Male; Menopause; Middle Aged; Patient Dropouts; Sertraline; Sex Factors; Treatment Outcome	2007
Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison. Human psychopharmacology, 2007, Volume: 22, Issue:7 Topics: Adult; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; India; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome	2007
Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:7 Topics: Adult; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sertraline; Thiazoles; Treatment Outcome	2007
Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement. Archives of general psychiatry, 2007, Volume: 64, Issue:9 Topics: Acute Disease; Affect; Arrhythmias, Cardiac; Comorbidity; Coronary Disease; Depressive Disorder, Major; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome	2007
Efficacy of Interpersonal Psychotherapy plus pharmacotherapy in chronically depressed inpatients. Journal of affective disorders, 2008, Volume: 109, Issue:1-2 Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Chronic Disease; Combined Modality Therapy; Depressive Disorder, Major; Drug Administration Schedule; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Prospective Studies; Psychotherapy, Group; Sertraline; Treatment Outcome	2008
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:2 Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sertraline; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Weight Gain; Withholding Treatment	2008
A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression. The American journal of psychiatry, 2008, Volume: 165, Issue:5 Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Humans; Middle Aged; Receptors, Corticotropin-Releasing Hormone; Sertraline; Surveys and Questionnaires; Treatment Outcome	2008
Changes in antidepressant metabolism and dosing across pregnancy and early postpartum. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Depression, Postpartum; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Humans; Pregnancy; Pregnancy Complications; Prenatal Diagnosis; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors	2008
An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial. American heart journal, 1999, Volume: 137, Issue:6 Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Canada; Depressive Disorder, Major; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Sertraline; Single-Blind Method; Time Factors; United States	1999
A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clinical therapeutics, 1999, Volume: 21, Issue:4 Topics: Adult; Aged; Bupropion; Delayed-Action Preparations; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Satisfaction; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological	1999
Comparative efficacy of sertraline vs. fluoxetine in patients age 70 or over with major depression. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 1999,Summer, Volume: 7, Issue:3 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Cognition; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Neuropsychological Tests; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Weight Loss	1999
Selective alteration of personality in response to noradrenergic and serotonergic antidepressant medication in depressed sample: evidence of non-specificity. Psychiatry research, 1999, Jun-30, Volume: 86, Issue:3 Topics: Adolescent; Adrenergic Uptake Inhibitors; Aged; Antidepressive Agents; Depressive Disorder, Major; Desipramine; Female; Humans; Male; Paroxetine; Personality; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1999
A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients. European psychiatry : the journal of the Association of European Psychiatrists, 1999, Volume: 14, Issue:1 Topics: Adolescent; Adult; Aged; Ambulatory Care; Depressive Disorder, Major; Double-Blind Method; Drug Tolerance; Female; Fluoxetine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index	1999
Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1999, Volume: 11, Issue:4 Topics: Adult; Aged; Bupropion; Delayed-Action Preparations; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Treatment Outcome	1999
An open study of sertraline in patients with major depression who failed to respond to moclobemide. The Australian and New Zealand journal of psychiatry, 1999, Volume: 33, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Moclobemide; Personality Inventory; Sertraline; Treatment Failure; Treatment Outcome	1999
Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features. Journal of affective disorders, 2000, Volume: 58, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Female; Fluoxetine; Humans; Immune Tolerance; Lymphocyte Activation; Male; Middle Aged; Paroxetine; Personality Inventory; Sertraline; Venlafaxine Hydrochloride	2000
Sertraline versus paroxetine in major depression: clinical outcome after six months of continuous therapy. Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:6 Topics: Adolescent; Adult; Analysis of Variance; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Logistic Models; Male; Middle Aged; Paroxetine; Personality Disorders; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2000
Double-blind, multicenter comparative study of sertraline versus amitriptyline in outpatients with major depression. Pharmacopsychiatry, 2000, Volume: 33, Issue:6 Topics: Adult; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Sertraline; Treatment Outcome	2000
Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. Depression and anxiety, 2001, Volume: 13, Issue:1 Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Analysis of Variance; Anxiety Disorders; Chronic Disease; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome	2001
Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care. Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:2 Topics: Adult; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Primary Health Care; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Statistics, Nonparametric	2001
Antidepressant efficacy and safety of low-dose sertraline and standard-dose imipramine for the treatment of depression in older adults: results from a double-blind, randomized, controlled clinical trial. International psychogeriatrics, 2001, Volume: 13, Issue:1 Topics: Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Brazil; Cost-Benefit Analysis; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Imipramine; Male; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Sertraline; Therapeutic Equivalency; Treatment Outcome	2001
The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trial. International clinical psychopharmacology, 2001, Volume: 16, Issue:3 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Sertraline; Treatment Outcome	2001
Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2001, Volume: 25, Issue:1 Topics: Adult; Aged; Anxiety; Bupropion; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Female; Humans; Male; Mental Status Schedule; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2001
Sertraline versus imipramine to prevent relapse in chronic depression. Journal of affective disorders, 2001, Volume: 65, Issue:1 Topics: Adult; Aged; Chronic Disease; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales; Recurrence; Sertraline	2001
Reflections of depression in acoustic measures of the patient's speech. Journal of affective disorders, 2001, Volume: 66, Issue:1 Topics: Aged; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nortriptyline; Sertraline; Sound Spectrography; Speech Acoustics; Treatment Outcome; Verbal Behavior	2001
Prefrontal repetitive transcranial magnetic stimulation as add on treatment in depression. Journal of neurology, neurosurgery, and psychiatry, 2001, Volume: 71, Issue:4 Topics: Adult; Combined Modality Therapy; Depressive Disorder, Major; Electric Stimulation Therapy; Electromagnetic Fields; Female; Humans; Male; Middle Aged; Prefrontal Cortex; Sertraline	2001
Cerebral blood flow in obsessive-compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non-responders. Psychiatry research, 2001, Nov-30, Volume: 108, Issue:2 Topics: Adult; Aged; Blood Flow Velocity; Cerebral Cortex; Depressive Disorder, Major; Desipramine; Dominance, Cerebral; Double-Blind Method; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Obsessive-Compulsive Disorder; Regional Blood Flow; Sertraline; Tomography, Emission-Computed, Single-Photon; Treatment Outcome	2001
Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. Journal of consulting and clinical psychology, 2001, Volume: 69, Issue:6 Topics: Cognitive Behavioral Therapy; Depressive Disorder, Major; Female; Humans; Male; Multiple Sclerosis; Psychotherapy, Group; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires	2001
Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia. Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:1 Topics: Adolescent; Adult; Aged; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sertraline; Treatment Outcome	2002
Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression. Archives of general psychiatry, 2002, Volume: 59, Issue:3 Topics: Adult; Cross-Over Studies; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Personality Inventory; Prospective Studies; Sertraline; Treatment Outcome	2002
Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia. Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:2 Topics: Acute Disease; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Fluoxetine; Humans; Paroxetine; Personality Inventory; Sertraline; Sleep Initiation and Maintenance Disorders; Treatment Outcome	2002
Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder, Major; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States	2002
Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. JAMA, 2002, 04-10, Volume: 287, Issue:14 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Hypericum; Male; Psychiatric Status Rating Scales; Regression Analysis; Sertraline; Statistics, Nonparametric	2002
Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation. Psychopharmacology, 2002, Volume: 161, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Antidepressive Agents; Confidence Intervals; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Mianserin; Middle Aged; Sertraline; Statistics, Nonparametric	2002
A randomized trial of a specific adherence enhancement program in sertraline-treated adults with major depressive disorder in a primary care setting. Progress in neuro-psychopharmacology & biological psychiatry, 2002, Volume: 26, Issue:3 Topics: Chi-Square Distribution; Depressive Disorder, Major; Double-Blind Method; Humans; Patient Compliance; Primary Health Care; Sertraline; Survival Analysis; Treatment Outcome	2002
Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs. Journal of affective disorders, 2002, Volume: 68, Issue:2-3 Topics: Adolescent; Adult; Aged; Canada; Combined Modality Therapy; Cost-Benefit Analysis; Depressive Disorder, Major; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Care Team; Primary Health Care; Psychotherapy; Sertraline; Single-Blind Method; Treatment Outcome	2002

Other Studies

193 other study(ies) available for sertraline and Depression, Involutional

Article	Year
Combinatorial pharmacogenomic algorithm is predictive of sertraline metabolism in patients with major depressive disorder. Psychiatry research, 2022, Volume: 308 Topics: Algorithms; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Depressive Disorder, Major; Humans; Sertraline; Treatment Outcome	2022
[Psychosis in an adolescent girl treated with sertraline]. Tijdschrift voor psychiatrie, 2022, Volume: 64, Issue:1 Topics: Adolescent; Antidepressive Agents; Child; Depressive Disorder, Major; Female; Humans; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline	2022
Common network effect-patterns after monoamine reuptake inhibition in dissociated hippocampus cultures. Journal of neural transmission (Vienna, Austria : 1996), 2022, Volume: 129, Issue:3 Topics: Antidepressive Agents; Depressive Disorder, Major; Hippocampus; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline	2022
Differential Response to Three Antidepressants in Patients with Major Depressive Episode Who Suffered Covid-19-Related Trauma. Current neuropharmacology, 2022, Nov-15, Volume: 20, Issue:12 Topics: Adult; Antidepressive Agents; COVID-19; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Quality of Life; Sertraline; Trazodone; Treatment Outcome; Vortioxetine	2022
Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy. Current neuropharmacology, 2023, Volume: 21, Issue:3 Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Humans; Italy; Paroxetine; Retrospective Studies; Sertraline; Venlafaxine Hydrochloride; Vortioxetine	2023
Changes in Sertraline Plasma Concentrations Across Pregnancy and Postpartum. Clinical pharmacology and therapeutics, 2022, Volume: 112, Issue:6 Topics: Cytochrome P-450 CYP2C19; Depressive Disorder, Major; Female; Humans; Postpartum Period; Pregnancy; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline	2022
Generalizability of treatment outcome prediction in major depressive disorder using structural MRI: A NeuroPharm study. NeuroImage. Clinical, 2022, Volume: 36 Topics: Antidepressive Agents; Depressive Disorder, Major; Humans; Magnetic Resonance Imaging; Sertraline; Treatment Outcome	2022
Effect of CYP2C19 polymorphisms on antidepressant prescription patterns and treatment emergent mania in bipolar disorder. The pharmacogenomics journal, 2023, Volume: 23, Issue:1 Topics: Amitriptyline; Antidepressive Agents; Bipolar Disorder; Clomipramine; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Depressive Disorder, Major; Humans; Mania; Polymorphism, Single Nucleotide; Sertraline	2023
Data driven clusters derived from resting state functional connectivity: Findings from the EMBARC study. Journal of psychiatric research, 2023, Volume: 158 Topics: Brain; Cerebral Cortex; Depressive Disorder, Major; Humans; Magnetic Resonance Imaging; Sertraline	2023
Synergistic anti-depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice. Neuropsychopharmacology reports, 2023, Volume: 43, Issue:1 Topics: Animals; Antidepressive Agents; Depressive Disorder, Major; Escitalopram; Fluoxetine; Mice; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming	2023
[Effect of Sertraline on Serum Cytokine Levels in Adolescents With First-Episode Major Depressive Disorder]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2023, Volume: 54, Issue:2 Topics: Adolescent; Blood Group Antigens; Cytokines; Depressive Disorder, Major; Humans; Inflammation; Interleukin-6; Sertraline; Tumor Necrosis Factor-alpha	2023
Population Pharmacokinetic Modeling to Inform Sertraline Dosing Optimization in Patients with Depression. Pharmacology, 2023, Volume: 108, Issue:4 Topics: Adult; Antidepressive Agents; Depression; Depressive Disorder, Major; Female; Humans; Male; Sertraline	2023
The effect of mobile-based logotherapy on depression, suicidal ideation, and hopelessness in patients with major depressive disorder: a mixed-methods study. Scientific reports, 2023, 09-22, Volume: 13, Issue:1 Topics: Depression; Depressive Disorder, Major; Humans; Logotherapy; Sertraline; Suicidal Ideation	2023
Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients. The pharmacogenomics journal, 2020, Volume: 20, Issue:3 Topics: Adolescent; Adult; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Sexual Dysfunction, Physiological; Young Adult	2020
Saffron vs sertraline for depression in the elderly. Psychiatry research, 2020, Volume: 285 Topics: Aged; Aged, 80 and over; Crocus; Depression; Depressive Disorder, Major; Double-Blind Method; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline	2020
Inflammation and Response to Sertraline Treatment in Patients With CKD and Major Depression. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2020, Volume: 75, Issue:3 Topics: Antidepressive Agents; Biomarkers; C-Reactive Protein; Depressive Disorder, Major; Humans; Inflammation; Renal Dialysis; Renal Insufficiency, Chronic; Sertraline; Treatment Outcome	2020
Plasma Indoleamine-2,3-Dioxygenase (IDO) is Increased in Drug-Naï ve Major Depressed Patients and Treatment with Sertraline and Ketoprofen Normalizes IDO in Association with Pro-Inflammatory and Immune- Regulatory Cytokines. CNS & neurological disorders drug targets, 2020, Volume: 19, Issue:1 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Biomarkers; Case-Control Studies; Cytokines; Depressive Disorder, Major; Female; Humans; Immune System; Immunologic Factors; Indoleamine-Pyrrole 2,3,-Dioxygenase; Iraq; Ketoprofen; Male; Middle Aged; Sertraline; Transforming Growth Factor beta1	2020
An electroencephalographic signature predicts antidepressant response in major depression. Nature biotechnology, 2020, Volume: 38, Issue:4 Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Humans; Machine Learning; Membrane Potentials; Models, Neurological; Predictive Value of Tests; Prefrontal Cortex; Reproducibility of Results; Sertraline; Transcranial Magnetic Stimulation; Treatment Outcome	2020
Antidepressant treatment strategy with an early onset of action improves the clinical outcome in patients with major depressive disorder and high anxiety: a multicenter and 6-week follow-up study. Chinese medical journal, 2020, Mar-20, Issue:6 Topics: Antidepressive Agents; Anxiety; Citalopram; Depressive Disorder, Major; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Least-Squares Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2020
Spontaneous thought-related network connectivity predicts sertraline effect on major depressive disorder. Brain imaging and behavior, 2021, Volume: 15, Issue:4 Topics: Antidepressive Agents; Brain; Depressive Disorder, Major; Humans; Magnetic Resonance Imaging; Sertraline	2021
Differentiating "types" of treatment dropout: Nonstarters in an RCT of prolonged exposure versus sertraline. Behaviour research and therapy, 2020, Volume: 135 Topics: Adolescent; Adult; Aged; Depressive Disorder, Major; Female; Humans; Implosive Therapy; Male; Middle Aged; Patient Dropouts; Patient Preference; Randomized Controlled Trials as Topic; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic; Young Adult	2020
Imaginal exposure exacerbation revisited: Deconstructing patient characteristics associated with worse reactions to the initiation of imaginal exposure in PTSD. Behaviour research and therapy, 2020, Volume: 135 Topics: Adult; Adult Survivors of Child Abuse; Child; Child Abuse; Child Abuse, Sexual; Depressive Disorder, Major; Disease Progression; Female; Humans; Implosive Therapy; Male; Mental Disorders; Middle Aged; Patient Dropouts; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic	2020
Differential response to SSRI versus Placebo and distinct neural signatures among data-driven subgroups of patients with major depressive disorder. Journal of affective disorders, 2021, 03-01, Volume: 282 Topics: Antidepressive Agents; Child; Depressive Disorder, Major; Humans; Sertraline	2021
Molecular imaging of the serotonin transporter availability and occupancy by antidepressant treatment in late-life depression. Neuropharmacology, 2021, 08-15, Volume: 194 Topics: Affect; Aged; Aged, 80 and over; Aging; Antidepressive Agents; Brain; Citalopram; Depressive Disorder, Major; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Imaging; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline	2021
Suspected Recurrence of Symptomatic COVID-19: Management During Inpatient Psychiatric Treatment. Journal of psychiatric practice, 2021, Mar-05, Volume: 27, Issue:2 Topics: Adult; Alcoholism; Antidepressive Agents; Antipsychotic Agents; Clozapine; COVID-19; COVID-19 Nucleic Acid Testing; Depressive Disorder, Major; Hospitals, Psychiatric; Humans; Inpatients; Male; Mirtazapine; Psychotic Disorders; Recurrence; SARS-CoV-2; Sertraline; Suicide, Attempted	2021
Impact of sertraline daily treatment regimen on adherence, persistence and healthcare resource utilisation in patients with major depressive disorder or obsessive-compulsive disorder: A real-world evidence analysis from the United States. International journal of clinical practice, 2021, Volume: 75, Issue:10 Topics: Depressive Disorder, Major; Humans; Medication Adherence; Obsessive-Compulsive Disorder; Patient Acceptance of Health Care; Retrospective Studies; Sertraline; United States	2021
Beta Adrenoceptor Polymorphism and Clinical Response to Sertraline in Major Depressive Patients. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2017, Volume: 20 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Female; Genotype; Humans; Male; Polymorphism, Genetic; Receptors, Adrenergic; Sertraline	2017
A Case of Fluoxetine-Induced Lower Extremity Ecchymosis. The primary care companion for CNS disorders, 2017, Jun-15, Volume: 19, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder, Major; Drug Substitution; Ecchymosis; Female; Fluoxetine; Humans; Lower Extremity; Sertraline	2017
Clinical Pearls in palliative medicine. Disease-a-month : DM, 2017, Volume: 63, Issue:6 Topics: Adult; Advance Care Planning; Aged; Antiemetics; Baclofen; Benzodiazepines; Constipation; Depressive Disorder, Major; Dyspnea; Female; Hiccup; Humans; Male; Methylphenidate; Middle Aged; Morphinans; Morphine; Nausea; Olanzapine; Palliative Medicine; Polyethylene Glycols; Prochlorperazine; Pruritus; Sertraline; Terminal Care; Walkers	2017
[Psychosis, Intoxication or Serotonin Syndrome? - A 20-Year Old Male with Ziprasidone und Sertraline]. Psychiatrische Praxis, 2017, Volume: 44, Issue:8 Topics: Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Lorazepam; Male; Piperazines; Psychotropic Drugs; Schizophrenia, Paranoid; Schizophrenic Psychology; Serotonin Syndrome; Sertraline; Substance-Related Disorders; Thiazoles; Young Adult	2017
Exacerbation of Depression Symptoms in the Presence of Dermatitis Herpetiformis Rash, Celiac Disease, and Low Cholesterol. The primary care companion for CNS disorders, 2017, Nov-09, Volume: 19, Issue:6 Topics: Antidepressive Agents; Celiac Disease; Cholesterol; Depressive Disorder, Major; Dermatitis Herpetiformis; Female; Humans; Middle Aged; Sertraline	2017
Venlafaxine and sertraline does not affect the expression of genes regulating stress response in female MDD patients. Psychiatria polska, 2017, Dec-30, Volume: 51, Issue:6 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression; Humans; Middle Aged; Real-Time Polymerase Chain Reaction; Receptors, Glucocorticoid; Sertraline; Severity of Illness Index; Venlafaxine Hydrochloride; Young Adult	2017
Stabilization treatment of remitted psychotic depression: the STOP-PD study. Acta psychiatrica Scandinavica, 2018, Volume: 138, Issue:3 Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Blood Glucose; Body Weight; Cholesterol; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Placebos; Psychotic Disorders; Remission Induction; Sertraline; Triglycerides	2018
The relationship between the serotonin 2A receptor gene -1438A/G and 102T/C polymorphisms and citalopram/sertraline-induced nausea in major depressed patients. Human psychopharmacology, 2018, Volume: 33, Issue:5 Topics: Adult; Alleles; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder, Major; Female; Genotype; Humans; Male; Nausea; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Sertraline; Vomiting; Young Adult	2018
Response to sertraline is influenced by GNβ3 gene G-350A variant in patients with major depressive disorder. European journal of clinical pharmacology, 2019, Volume: 75, Issue:2 Topics: Adult; Alleles; Antidepressive Agents; Depressive Disorder, Major; Female; Genotype; Heterotrimeric GTP-Binding Proteins; Humans; Male; Polymorphism, Single Nucleotide; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2019
Functional connectivity predictors of acute depression treatment outcome. International psychogeriatrics, 2019, Volume: 31, Issue:12 Topics: Aged; Connectome; Depressive Disorder, Major; Executive Function; Female; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Multivariate Analysis; Prefrontal Cortex; Psychiatric Status Rating Scales; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2019
Increased ventromedial prefrontal cortex activity and connectivity predict poor sertraline treatment outcome in late-life depression. International journal of geriatric psychiatry, 2019, Volume: 34, Issue:5 Topics: Aged; Aged, 80 and over; Connectome; Depressive Disorder, Major; Executive Function; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Prefrontal Cortex; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline	2019
Plasma serotonin levels are associated with antidepressant response to SSRIs. Journal of affective disorders, 2019, 05-01, Volume: 250 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Treatment Outcome	2019
A functional variant in the serotonin receptor 7 gene (HTR7), rs7905446, is associated with good response to SSRIs in bipolar and unipolar depression. Molecular psychiatry, 2020, Volume: 25, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Animals; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Receptors, Serotonin; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult	2020
Examining raphe-amygdala structural connectivity as a biological predictor of SSRI response. Journal of affective disorders, 2019, 09-01, Volume: 256 Topics: Adult; Amygdala; Anisotropy; Antidepressive Agents; Depressive Disorder, Major; Female; Hippocampus; Humans; Male; Middle Aged; Raphe Nuclei; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline	2019
Total and ionized calcium and magnesium are significantly lowered in drug-naïve depressed patients: effects of antidepressants and associations with immune activation. Metabolic brain disease, 2019, Volume: 34, Issue:5 Topics: Adult; Antidepressive Agents; Calcium; Depressive Disorder, Major; Female; Humans; Ketoprofen; Magnesium; Male; Middle Aged; Sertraline; Treatment Outcome	2019
Influence of baseline severity on the effects of SSRIs in depression: an item-based, patient-level post-hoc analysis. The lancet. Psychiatry, 2019, Volume: 6, Issue:9 Topics: Antidepressive Agents; Citalopram; Clinical Trials as Topic; Depression; Depressive Disorder, Major; Fluoxetine; Humans; Longitudinal Studies; Outcome Assessment, Health Care; Paroxetine; Placebos; Psychiatric Status Rating Scales; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index	2019
A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline. CNS spectrums, 2013, Volume: 18, Issue:3 Topics: Acetamides; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder; Depressive Disorder, Major; Female; Fluoxetine; Humans; Hypnotics and Sedatives; Male; Middle Aged; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome; Young Adult	2013
Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome. Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:10 Topics: Aged; Akathisia, Drug-Induced; Antiparkinson Agents; Brain Diseases; Delusions; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Humans; Indans; Myoclonus; Neuroprotective Agents; Parkinson Disease; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline	2013
Treatment course with antidepressant therapy in late-life depression. The American journal of psychiatry, 2012, Volume: 169, Issue:11 Topics: Aged; Amygdala; Antidepressive Agents; Brain; Caudate Nucleus; Cerebral Cortex; Cognition Disorders; Depressive Disorder, Major; Female; Frontal Lobe; Hippocampus; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Neuropsychological Tests; Organ Size; Parahippocampal Gyrus; Personality Inventory; Prospective Studies; Psychometrics; Reaction Time; Sertraline; Treatment Outcome	2012
Treatment course with antidepressant therapy in late-life depression. The American journal of psychiatry, 2013, Volume: 170, Issue:4 Topics: Antidepressive Agents; Brain; Cerebral Cortex; Depressive Disorder, Major; Female; Humans; Male; Personality Inventory; Sertraline	2013
Response to Irion et al. letter. The American journal of psychiatry, 2013, Volume: 170, Issue:4 Topics: Antidepressive Agents; Brain; Cerebral Cortex; Depressive Disorder, Major; Female; Humans; Male; Personality Inventory; Sertraline	2013
Results for behavioural activation are overstated. The British journal of psychiatry : the journal of mental science, 2013, Volume: 202 Topics: Antidepressive Agents; Behavior Therapy; Depressive Disorder, Major; Female; Humans; Male; Outcome Assessment, Health Care; Sertraline	2013
Relationship between SSRI-induced sexual dysfunction and central serotonergic activity based on the loudness dependence of auditory evoked potentials. Psychopharmacology, 2014, Volume: 231, Issue:3 Topics: Acoustic Stimulation; Adult; Brain; Citalopram; Cross-Sectional Studies; Depressive Disorder, Major; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Hypnotics and Sedatives; Loudness Perception; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Sexual Dysfunction, Physiological	2014
Is sertraline plus transcranial direct current stimulation the future of effective depression treatment? Journal of comparative effectiveness research, 2013, Volume: 2, Issue:3 Topics: Antidepressive Agents; Combined Modality Therapy; Depressive Disorder, Major; Electric Stimulation Therapy; Epidemiologic Methods; Forecasting; Humans; Sertraline	2013
Journal Watch review of Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial. Journal of the American Psychoanalytic Association, 2014, Volume: 62, Issue:1 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Psychotherapy, Brief; Sertraline	2014
Authors' reply. The British journal of psychiatry : the journal of mental science, 2013, Volume: 202 Topics: Antidepressive Agents; Behavior Therapy; Depressive Disorder, Major; Female; Humans; Male; Outcome Assessment, Health Care; Sertraline	2013
Depression in a Pakistani woman. The American journal of psychiatry, 2014, Volume: 171, Issue:7 Topics: Adaptation, Psychological; Adult; Combined Modality Therapy; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Islam; Life Change Events; Recurrence; Religion and Psychology; Sertraline; Social Environment; Social Values; Spiritual Therapies	2014
Increased association over time between regional frontal lobe BOLD change magnitude and cardiac vagal control with sertraline treatment for major depression. Psychiatry research, 2014, Dec-30, Volume: 224, Issue:3 Topics: Adult; Depressive Disorder, Major; Electrocardiography; Female; Frontal Lobe; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prefrontal Cortex; Prognosis; Respiratory Sinus Arrhythmia; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2014
ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression. The pharmacogenomics journal, 2015, Volume: 15, Issue:4 Topics: Adult; Alleles; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chronic Disease; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Genotype; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Polymorphism, Single Nucleotide; Sertraline; Treatment Outcome; White People	2015
Prophylactic efficacy of fluoxetine, escitalopram, sertraline, paroxetine, and concomitant psychotherapy in major depressive disorder: outcome after long-term follow-up. Psychiatry research, 2015, Feb-28, Volume: 225, Issue:3 Topics: Adult; Citalopram; Cognitive Behavioral Therapy; Cohort Studies; Combined Modality Therapy; Depressive Disorder, Major; Female; Fluoxetine; Follow-Up Studies; Humans; Long-Term Care; Male; Middle Aged; Paroxetine; Prospective Studies; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2015
[Treatment of syndrome of inappropriate antidiuretic hormone secretion due to sertraline]. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2015, Jan-01, Volume: 39, Issue:1 Topics: Aged, 80 and over; Antidepressive Agents; Depressive Disorder, Major; Female; Humans; Inappropriate ADH Syndrome; Sertraline; Sodium	2015
Real-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia. Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists, 2016, Volume: 8, Issue:1 Topics: Adult; Asia, Eastern; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Middle Aged; Pain; Paroxetine; Prospective Studies; Quality of Life; Regression Analysis; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome	2016
Seeing double: sertraline and diplopia: a case report. International journal of psychiatry in medicine, 2015, Volume: 49, Issue:1 Topics: Adult; Depressive Disorder, Major; Diplopia; Humans; Male; Photophobia; Sertraline; Stress Disorders, Post-Traumatic; Visual Acuity	2015
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. Journal of affective disorders, 2015, Jul-15, Volume: 180 Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2015
Inflammation Markers and Major Depressive Disorder in Patients With Chronic Heart Failure: Results From the Sertraline Against Depression and Heart Disease in Chronic Heart Failure Study. Psychosomatic medicine, 2015, Volume: 77, Issue:7 Topics: Aged; Biomarkers; Chronic Disease; Comorbidity; Depressive Disorder, Major; Female; Heart Failure; Humans; Inflammation; Male; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline	2015
Clinically Useful Genetic Markers of Antidepressant Response: How Do We Get There From Here? The American journal of psychiatry, 2015, Aug-01, Volume: 172, Issue:8 Topics: Antidepressive Agents; Anxiety; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Sertraline	2015
Partial Amelioration of Medial Visceromotor Network Dysfunction in Major Depression by Sertraline. Psychosomatic medicine, 2015, Volume: 77, Issue:7 Topics: Adult; Autonomic Nervous System Diseases; Depressive Disorder, Major; Electrocardiography; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Outcome Assessment, Health Care; Respiratory Sinus Arrhythmia; Selective Serotonin Reuptake Inhibitors; Sertraline; Vagus Nerve	2015
Effects of antidepressant treatment on total antioxidant capacity and free radical levels in patients with major depressive disorder. Psychiatry research, 2015, Dec-15, Volume: 230, Issue:2 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Female; Free Radicals; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Oxidative Stress; Prospective Studies; Sertraline; Young Adult	2015
Establishing the cut-off score for remission and severity-ranges on the Psychotic Depression Assessment Scale (PDAS). Journal of affective disorders, 2016, Jan-15, Volume: 190 Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Olanzapine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; ROC Curve; Sertraline; Severity of Illness Index	2016
Major depressive disorder in an adolescent with Turner syndrome: a case report. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2016, Volume: 32, Issue:5 Topics: Adolescent; Antidepressive Agents; Depressive Disorder, Major; Estradiol; Female; Humans; Sertraline; Treatment Outcome; Turner Syndrome	2016
Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients. International journal of clinical pharmacy, 2016, Volume: 38, Issue:2 Topics: Adolescent; Adult; Antidepressive Agents; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Sertraline; Young Adult	2016
SSRI-antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP-PD study. Human psychopharmacology, 2016, Volume: 31, Issue:3 Topics: Adult; Age Factors; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Half-Life; Humans; Male; Middle Aged; Models, Biological; Nonlinear Dynamics; Olanzapine; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors	2016
Why is mechanism of action important in antidepressant treatment? The Journal of clinical psychiatry, 2016, Volume: 77, Issue:5 Topics: Adult; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Drug Substitution; Female; Follow-Up Studies; Humans; Sertraline; Surveys and Questionnaires	2016
A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors. Translational psychiatry, 2016, 06-07, Volume: 6, Issue:6 Topics: Adult; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2016
Decreased functional connectivity to posterior cingulate cortex in major depressive disorder. Psychiatry research. Neuroimaging, 2016, Sep-30, Volume: 255 Topics: Adult; Cerebral Cortex; Depressive Disorder, Major; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Nerve Net; Sertraline; Young Adult	2016
Which SSRIs most effectively treat depression in adolescents? The Journal of family practice, 2016, Volume: 65, Issue:9 Topics: Adolescent; Adolescent Behavior; Antidepressive Agents; Behavior Therapy; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline	2016
Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland. Expert review of pharmacoeconomics & outcomes research, 2017, Volume: 17, Issue:3 Topics: Acetamides; Antidepressive Agents; Bupropion; Cost-Benefit Analysis; Decision Trees; Depressive Disorder, Major; Finland; Humans; Markov Chains; Models, Theoretical; Piperazines; Recurrence; Sertraline; Sulfides; Treatment Outcome; Venlafaxine Hydrochloride; Vortioxetine	2017
Antidepressant Medication Prescribing Practices for Treatment of Major Depressive Disorder. Psychiatric services (Washington, D.C.), 2017, 02-01, Volume: 68, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Drug Prescriptions; Female; Humans; Insurance, Health; Male; Middle Aged; Practice Patterns, Physicians'; Sertraline; Trazodone; United States; Young Adult	2017
Kynurenine 3-monooxygenase is implicated in antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions. Behavioural brain research, 2017, 01-15, Volume: 317 Topics: Animals; Antidepressive Agents; Biogenic Monoamines; Depressive Disorder, Major; Disease Models, Animal; Exploratory Behavior; Food Preferences; Hippocampus; Imipramine; Kynurenine; Kynurenine 3-Monooxygenase; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Sertraline; Sucrose; Swimming; Tryptophan	2017
Generic formulations of psychotropic medications and treatment response. Journal of psychiatry & neuroscience : JPN, 2017, Volume: 42, Issue:2 Topics: Adult; Depressive Disorder, Major; Drug Substitution; Drugs, Generic; Humans; Male; Psychotropic Drugs; Recurrence; Sertraline; Treatment Outcome	2017
A 35-year-old woman with low mood and concerns about her alcohol use. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2017, 02-27, Volume: 189, Issue:8 Topics: Adult; Alcoholism; Antidepressive Agents; Counseling; Depressive Disorder, Major; Female; Humans; Naltrexone; Narcotic Antagonists; Patient Care Planning; Sertraline	2017
Sertraline-associated hair loss. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:7 Topics: Adult; Alopecia; Depressive Disorder, Major; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2008
Flat dose-response curves for efficacy: what do they mean to the clinician? Journal of psychiatric practice, 2008, Volume: 14, Issue:4 Topics: Attitude of Health Personnel; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluoxetine; Humans; Neurotransmitter Uptake Inhibitors; Paroxetine; Physicians; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome; United States; United States Food and Drug Administration	2008
[A place for SSRIs in the treatment of severely depressed children and adolescents]. Nederlands tijdschrift voor geneeskunde, 2008, Aug-02, Volume: 152, Issue:31 Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide; Venlafaxine Hydrochloride	2008
Addition of risperidone to sertraline improves sertraline-resistant refractory depression without influencing plasma concentrations of sertraline and desmethylsertraline. Human psychopharmacology, 2008, Volume: 23, Issue:8 Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Depressive Disorder, Major; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Risperidone; Sertraline	2008
Predictors of response to sertraline in patients with major depression. Human psychopharmacology, 2008, Volume: 23, Issue:8 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Cohort Studies; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Genetic Predisposition to Disease; Hospitals; Humans; Japan; Male; Middle Aged; Rehabilitation Centers; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Treatment Outcome; Young Adult	2008
Practical application of therapeutic drug monitoring: a tale of two patients. Journal of psychiatric practice, 2008, Volume: 14, Issue:5 Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Drug Interactions; Female; Humans; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline	2008
Should tactile sensation impairment be considered in pharmacotherapy of pervasive developmental disorders? A case report. Neuro endocrinology letters, 2008, Volume: 29, Issue:6 Topics: Adult; Antidepressive Agents; Asperger Syndrome; Child; Child Development Disorders, Pervasive; Depressive Disorder, Major; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Touch Perception; Treatment Outcome	2008
Violent parasomnia associated with a selective serotonin reuptake inhibitor: a case report. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:12 Topics: Aged; Antidepressive Agents; Arousal; Combat Disorders; Depressive Disorder, Major; Dose-Response Relationship, Drug; Humans; Male; Polysomnography; Selective Serotonin Reuptake Inhibitors; Sertraline; Veterans; Violence	2008
Psychomotor changes in major depressive disorder during sertraline treatment. Neuropsychobiology, 2009, Volume: 59, Issue:1 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Female; Humans; Linear Models; Male; Multivariate Analysis; Neuropsychological Tests; Psychomotor Performance; Selective Serotonin Reuptake Inhibitors; Sertraline	2009
31Phosphorus magnetic resonance spectroscopy study of tissue specific changes in high energy phosphates before and after sertraline treatment of geriatric depression. International journal of geriatric psychiatry, 2009, Volume: 24, Issue:8 Topics: Aged; Antidepressive Agents; Case-Control Studies; Depressive Disorder, Major; Energy Metabolism; Female; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Male; Middle Aged; Mitochondrial Diseases; Organophosphates; Phosphorus Isotopes; Sertraline	2009
Antidepressant switching among adherent patients treated for depression. Psychiatric services (Washington, D.C.), 2009, Volume: 60, Issue:5 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Drug Administration Schedule; Humans; Mianserin; Middle Aged; Mirtazapine; Patient Compliance; Sertraline; Trazodone; Venlafaxine Hydrochloride; Young Adult	2009
Early adversity in chronic depression: clinical correlates and response to pharmacotherapy. Depression and anxiety, 2009, Volume: 26, Issue:8 Topics: Adolescent; Adult; Age of Onset; Aged; Algorithms; Antidepressive Agents; Anxiety Disorders; Bupropion; Child; Child Abuse, Sexual; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Life Change Events; Male; Mianserin; Middle Aged; Mirtazapine; Parenting; Risk Factors; Self Concept; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2009
Putative neuroleptic malignant syndrome associated with sertraline withdrawal. Journal of clinical psychopharmacology, 2009, Volume: 29, Issue:3 Topics: Aged; Depressive Disorder, Major; Female; Humans; Neuroleptic Malignant Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome	2009
Persistence and compliance to antidepressant treatment in patients with depression: a chart review. BMC psychiatry, 2009, Jun-16, Volume: 9 Topics: Adolescent; Aged; Aged, 80 and over; Antidepressive Agents; Benzodiazepines; Depressive Disorder, Major; Female; Humans; Japan; Male; Medication Adherence; Middle Aged; Patient Compliance; Patient Dropouts; Physician-Patient Relations; Retrospective Studies; Sertraline	2009
What would you choose? Sertraline or prolonged exposure in community and PTSD treatment seeking women. Depression and anxiety, 2009, Volume: 26, Issue:8 Topics: Adolescent; Adult; Antidepressive Agents; Choice Behavior; Chronic Disease; Comorbidity; Depressive Disorder, Major; Female; Humans; Implosive Therapy; Interview, Psychological; Middle Aged; Outcome and Process Assessment, Health Care; Patient Participation; Personality Inventory; Psychometrics; Sertraline; Stress Disorders, Post-Traumatic; Young Adult	2009
Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression. Brain research bulletin, 2009, Sep-28, Volume: 80, Issue:3 Topics: Adult; Analysis of Variance; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Combined Modality Therapy; Depressive Disorder, Major; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Sertraline; Severity of Illness Index; Sleep; Sleep Deprivation	2009
Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women? The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2009, Volume: 10, Issue:4 Pt 2 Topics: Adrenergic Uptake Inhibitors; Adult; Age Factors; Antidepressive Agents; Climacteric; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Middle Aged; Morpholines; Personality Inventory; Reboxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride; Young Adult	2009
Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Archives of general psychiatry, 2009, Volume: 66, Issue:9 Topics: Acute Coronary Syndrome; Depressive Disorder, Major; Female; Follow-Up Studies; Guideline Adherence; Hospitalization; Humans; Longitudinal Studies; Male; Medication Adherence; Middle Aged; Proportional Hazards Models; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index	2009
Effects of paroxetine and sertraline on low-density lipoprotein cholesterol: an observational cohort study. CNS drugs, 2009, Volume: 23, Issue:10 Topics: Adult; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Paroxetine; Risk Factors; Sertraline; Time Factors	2009
HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort. Neuromolecular medicine, 2010, Volume: 12, Issue:3 Topics: Asian People; Depressive Disorder, Major; Fluvoxamine; Genotype; Haplotypes; Humans; Linkage Disequilibrium; Paroxetine; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2010
Antidepressant pharmacotherapy in adults with type 2 diabetes: rates and predictors of initial response. Diabetes care, 2010, Volume: 33, Issue:3 Topics: Adult; Aged; Antidepressive Agents; Biomarkers, Pharmacological; Bupropion; Depressive Disorder, Major; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Sertraline; Treatment Outcome	2010
Association analysis of SIGMAR1 with major depressive disorder and SSRI response. Neuropharmacology, 2010, Volume: 58, Issue:7 Topics: Adult; Case-Control Studies; Depressive Disorder, Major; Female; Fluvoxamine; Genetic Association Studies; Genotype; Humans; Japan; Logistic Models; Male; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Receptors, sigma; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Sigma-1 Receptor; Time Factors; Treatment Outcome	2010
Omega-3 fatty acids for CHD with depression. JAMA, 2010, Mar-03, Volume: 303, Issue:9 Topics: Antidepressive Agents; Depressive Disorder, Major; Fatty Acids, Omega-3; Psychiatric Status Rating Scales; Reproducibility of Results; Sertraline; Treatment Outcome	2010
Sertraline-induced serotonin syndrome followed by mirtazapine reaction. Progress in neuro-psychopharmacology & biological psychiatry, 2010, Aug-16, Volume: 34, Issue:6 Topics: Adult; Antidepressive Agents; Cyproheptadine; Depressive Disorder, Major; Humans; Male; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Syndrome; Sertraline; Treatment Outcome	2010
Treatments for alcohol dependence: rethinking the role of comorbidity and clinical subtypes. The American journal of psychiatry, 2010, Volume: 167, Issue:6 Topics: Alcoholism; Cognitive Behavioral Therapy; Comorbidity; Depressive Disorder, Major; Humans; Naltrexone; Selective Serotonin Reuptake Inhibitors; Sertraline	2010
Donepezil and concurrent sertraline treatment is associated with increased hippocampal volume in a patient with depression. The Journal of clinical psychiatry, 2010, Volume: 71, Issue:6 Topics: Adult; Alzheimer Disease; Atrophy; Cholinesterase Inhibitors; Cognition Disorders; Depressive Disorder, Major; Diagnosis, Differential; Donepezil; Drug Therapy, Combination; Female; Follow-Up Studies; Functional Laterality; Hippocampus; Humans; Indans; Magnetic Resonance Imaging; Piperidines; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2010
Milnacipran-associated urinary retention: a case report. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:5 Topics: Adult; Cyclopropanes; Depressive Disorder, Major; Follow-Up Studies; Humans; Male; Milnacipran; Sertraline; Urinary Retention	2010
Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder. Archives of general psychiatry, 2010, Volume: 67, Issue:11 Topics: Adult; Affect; Amygdala; Awareness; Brain Mapping; Depressive Disorder, Major; Emotions; Facial Expression; Female; Form Perception; Happiness; Humans; Magnetic Resonance Imaging; Male; Perceptual Masking; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Perception; Wechsler Scales	2010
Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI. International clinical psychopharmacology, 2011, Volume: 26, Issue:4 Topics: Depressive Disorder, Major; Fluoxetine; Humans; Hypericum; Logistic Models; Outpatients; Phytotherapy; Plant Preparations; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2011
Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population. Journal of affective disorders, 2011, Volume: 133, Issue:1-2 Topics: Adult; Asian People; Case-Control Studies; Circadian Clocks; Depressive Disorder, Major; Endopeptidases; Female; Fluvoxamine; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Male; Paroxetine; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Ubiquitin	2011
Clinical practice. Depression during pregnancy. The New England journal of medicine, 2011, Oct-27, Volume: 365, Issue:17 Topics: Antidepressive Agents; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Psychotherapy; Sertraline; Young Adult	2011
Sertraline (Zoloft) response in major depressive disorder is not associated with three 5-HT1A receptor gene polymorphisms (rs6295, rs10042486, or rs1364043) in Chinese-Han patients. Psychiatric genetics, 2012, Volume: 22, Issue:5 Topics: Adolescent; Adult; Antidepressive Agents; Asian People; China; Depressive Disorder, Major; Ethnicity; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT1A; Sertraline; Young Adult	2012
Augmentation with ramelteon to achieve remission in geriatric major depression. Psychiatry and clinical neurosciences, 2012, Volume: 66, Issue:1 Topics: Aged; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Indenes; Male; Receptors, Melatonin; Sertraline; Sleep Initiation and Maintenance Disorders	2012
Questions raised by the failure of a trial of short-term psychodynamic therapy versus pharmacotherapy for major depressive disorder. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:1 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Drug Approval; Female; Humans; Male; Psychotherapy, Brief; Randomized Controlled Trials as Topic; Sertraline; United States Food and Drug Administration; Venlafaxine Hydrochloride	2012
Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression. Journal of psychiatric research, 2012, Volume: 46, Issue:8 Topics: Aged; Aged, 80 and over; Analysis of Variance; Antidepressive Agents; Blood Platelets; Depressive Disorder, Major; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Immunoenzyme Techniques; Longitudinal Studies; Male; Middle Aged; Phosphorylation; Residence Characteristics; Sertraline	2012
Evidence for short-term psychodynamic psychotherapy for depression. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:5 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Psychotherapy, Brief; Sertraline	2012
Discerning the effects of psychopathology and antidepressant treatment on sexual dsyfunction. International journal of psychiatry in clinical practice, 2013, Volume: 17, Issue:3* Topics: Adult; Case-Control Studies; Citalopram; Cross-Sectional Studies; Depressive Disorder, Major; Female; Humans; Male; Prevalence; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Treatment Outcome; Turkey; Young Adult	2013
Progressive neuropsychiatric and brain abnormalities after smoke inhalation. BMJ case reports, 2012, Aug-08, Volume: 2012 Topics: Activities of Daily Living; Brain; Cognition Disorders; Depressive Disorder, Major; DNA Damage; Fluorodeoxyglucose F18; Fructose; Humans; Male; Memory, Long-Term; Methylphenidate; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Oxidative Stress; Positron-Emission Tomography; Radiopharmaceuticals; Sertraline; Smoke Inhalation Injury; Time Factors; Topiramate; Valproic Acid	2012
Serotonin transporter genotype and function in relation to antidepressant response in Koreans. Psychopharmacology, 2013, Volume: 225, Issue:2 Topics: Adult; Aged; Asian People; Blood Platelets; Case-Control Studies; Depressive Disorder, Major; Female; Fluoxetine; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Promoter Regions, Genetic; Republic of Korea; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Treatment Outcome	2013
Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STARD trial. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2012, Volume: 95 Suppl 5* Topics: Adult; Antidepressive Agents; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Models, Economic; Quality of Life; Sertraline; Thailand; Venlafaxine Hydrochloride	2012
Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial? The Journal of clinical psychiatry, 2012, Volume: 73, Issue:11 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Humans; Intention; Male; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Personality Inventory; Primary Health Care; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Factors; Sertraline; Suicidal Ideation; Suicide, Attempted; Thinking; Venlafaxine Hydrochloride	2012
Late-life depression research: lessons learned from the metabolic syndrome. The American journal of psychiatry, 2012, Volume: 169, Issue:11 Topics: Antidepressive Agents; Brain; Cerebral Cortex; Depressive Disorder, Major; Female; Humans; Male; Personality Inventory; Sertraline	2012
Dysregulated relationship of inflammation and oxidative stress in major depression. Brain, behavior, and immunity, 2013, Volume: 31 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Female; Humans; Inflammation; Interleukin-10; Interleukin-6; Male; Middle Aged; Oxidative Stress; Sertraline; Treatment Outcome	2013
Increased oxidative stress in patients with depression and its relationship to treatment. Psychiatry research, 2013, Apr-30, Volume: 206, Issue:2-3 Topics: Adult; Antidepressive Agents; Biomarkers; Bupropion; Case-Control Studies; Depressive Disorder, Major; F2-Isoprostanes; Female; Humans; Male; Oxidative Stress; Sertraline; Severity of Illness Index; Young Adult	2013
Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression. Journal of affective disorders, 2013, Volume: 148, Issue:2-3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Australia; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Humans; Hypericum; Markov Chains; Middle Aged; Models, Economic; Phytotherapy; Plant Preparations; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2013
Antidepressant-selective gynecomastia. The Annals of pharmacotherapy, 2013, Volume: 47, Issue:1 Topics: Aged; Amlodipine; Antidepressive Agents; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Duloxetine Hydrochloride; Fluorobenzenes; Gynecomastia; Humans; Male; Pyrimidines; Rosuvastatin Calcium; Sertraline; Sulfonamides; Thiophenes	2013
Salivary cortisol in women with major depressive disorder under selective serotonin reuptake inhibitors therapy. Archives of women's mental health, 2013, Volume: 16, Issue:2 Topics: Adult; Aged; Case-Control Studies; Chromatography, High Pressure Liquid; Cluster Analysis; Depressive Disorder, Major; Female; Humans; Hydrocortisone; Middle Aged; Poland; Principal Component Analysis; Saliva; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2013
A comparison of characteristics of depressed patients and efficacy of sertraline and amitriptyline between Japan and the West. Journal of affective disorders, 2002, Volume: 70, Issue:2 Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Depressive Disorder, Major; Europe; Female; Humans; Japan; Male; Middle Aged; Sertraline; Surveys and Questionnaires	2002
Treatment of depression following acute myocardial infarction. JAMA, 2002, Aug-14, Volume: 288, Issue:6 Topics: Angina, Unstable; Depressive Disorder, Major; Humans; Myocardial Infarction; Selective Serotonin Reuptake Inhibitors; Sertraline	2002
Sertraline versus fluoxetine in the treatment of major depression: a combined analysis of five double-blind comparator studies. International clinical psychopharmacology, 2003, Volume: 18, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2003
Long-term sertraline treatment and peripheral biochemical markers in female depressed patients. Progress in neuro-psychopharmacology & biological psychiatry, 2003, Volume: 27, Issue:5 Topics: Adult; Aged; Analysis of Variance; Biomarkers; Chi-Square Distribution; Depressive Disorder, Major; Female; Humans; Middle Aged; Monoamine Oxidase; Serotonin; Sertraline; Treatment Outcome	2003
Psychopharmacological treatment of major depressive disorder in children and adolescents. JAMA, 2003, Aug-27, Volume: 290, Issue:8 Topics: Adolescent; Antidepressive Agents; Child; Depressive Disorder, Major; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide	2003
Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder. JAMA, 2004, Jan-07, Volume: 291, Issue:1 Topics: Adolescent; Antidepressive Agents; Child; Depressive Disorder, Major; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline	2004
Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder. JAMA, 2004, Jan-07, Volume: 291, Issue:1 Topics: Adolescent; Antidepressive Agents; Child; Depressive Disorder, Major; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline	2004
Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder. JAMA, 2004, Jan-07, Volume: 291, Issue:1 Topics: Adolescent; Antidepressive Agents; Child; Depressive Disorder, Major; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline	2004
Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder. JAMA, 2004, Jan-07, Volume: 291, Issue:1 Topics: Adolescent; Antidepressive Agents; Child; Depressive Disorder, Major; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline	2004
Selective serotonin reuptake inhibitor treatment of major depressive disorder in children and adolescents. Current psychiatry reports, 2004, Volume: 6, Issue:2 Topics: Adolescent; Antidepressive Agents; Child; Depressive Disorder, Major; Double-Blind Method; Humans; Placebos; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2004
Sertraline and the Cheshire cat in geriatric depression. The American journal of psychiatry, 2004, Volume: 161, Issue:4 Topics: Aged; Depressive Disorder, Major; Humans; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2004
A pilot study of brief interpersonal psychotherapy for depression among women. Psychiatric services (Washington, D.C.), 2004, Volume: 55, Issue:4 Topics: Case-Control Studies; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Interpersonal Relations; Pilot Projects; Psychotherapy; Psychotherapy, Brief; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires	2004
Sertraline and depression in children. JAMA, 2004, Apr-07, Volume: 291, Issue:13 Topics: Adolescent; Antidepressive Agents; Child; Depressive Disorder, Major; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline	2004
Visual hallucinations with sertraline. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:3 Topics: Aged; Antidepressive Agents; Depressive Disorder, Major; Female; Hallucinations; Humans; Sertraline	2004
Sertraline and the Cheshire cat in geriatric depression. The American journal of psychiatry, 2004, Volume: 161, Issue:6 Topics: Aged; Depressive Disorder, Major; Humans; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2004
Length of therapy with selective serotonin reuptake inhibitors and tricyclic antidepressants in Australia. The Australian and New Zealand journal of psychiatry, 2004, Volume: 38, Issue:6 Topics: Antidepressive Agents, Tricyclic; Cohort Studies; Depressive Disorder, Major; Dothiepin; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors	2004
A case of "double" depression under outpatient treatment conditions. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2004, Volume: 5, Issue:3 Topics: Adult; Ambulatory Care; Anticonvulsants; Carbamazepine; Clonazepam; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Dysthymic Disorder; Electroencephalography; Epilepsy, Temporal Lobe; Female; Humans; International Classification of Diseases; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index	2004
Repetition of serotonin syndrome after reexposure to SSRI--a case report. Pharmacopsychiatry, 2004, Volume: 37, Issue:5 Topics: Citalopram; Depressive Disorder, Major; Female; Humans; Middle Aged; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline	2004
Compliance with SSRI medication during 6 months of treatment for major depression: an evaluation by determination of repeated serum drug concentrations. Journal of affective disorders, 2004, Nov-01, Volume: 82, Issue:3 Topics: Adolescent; Adult; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Monitoring; Female; Humans; Male; Patient Compliance; Periodicity; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors	2004
Validation of the Bech-Rafaelsen Melancholia Scale and the Hamilton Depression Scale in patients with major depression; is the total score a valid measure of illness severity? Acta psychiatrica Scandinavica, 2005, Volume: 111, Issue:2 Topics: Adolescent; Adult; Aged; Depressive Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Middle Aged; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Surveys and Questionnaires	2005
Selective serotonin reuptake inhibitors (SSRIs) and depression after myocardial infarction (MI). Journal of psychiatry & neuroscience : JPN, 2005, Volume: 30, Issue:2 Topics: Depressive Disorder, Major; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline	2005
Sertraline for recurrent major depression. The American journal of psychiatry, 2005, Volume: 162, Issue:5 Topics: Depressive Disorder, Major; Humans; Placebos; Randomized Controlled Trials as Topic; Research Design; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Therapeutic Human Experimentation; Treatment Outcome	2005
Effects of sertraline on depressive symptoms and attentional and executive functions in major depression. Depression and anxiety, 2005, Volume: 21, Issue:2 Topics: Adult; Aged; Attention; Cognition Disorders; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Psychomotor Performance; Reaction Time; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Thyroid Function Tests	2005
Adolescents' response to antidepressant treatment in a community mental health center. Community mental health journal, 2005, Volume: 41, Issue:1 Topics: Adolescent; Adolescent Psychiatry; Algorithms; Antidepressive Agents; Child; Child Psychiatry; Citalopram; Community Mental Health Centers; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2005
Parkinsonism and elevated lactic acid with sertraline. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2005, Volume: 50, Issue:5 Topics: Basal Ganglia; Depressive Disorder, Major; Female; Humans; Lactic Acid; Magnetic Resonance Imaging; Middle Aged; Parkinson Disease, Secondary; Selective Serotonin Reuptake Inhibitors; Sertraline	2005
Sertraline- and mirtazapine-induced severe neutropenia. The American journal of psychiatry, 2005, Volume: 162, Issue:7 Topics: Adult; Agranulocytosis; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Female; Humans; Mianserin; Mirtazapine; Neutropenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2005
An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches. Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Sertraline; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride	2005
Exacerbation of migraine attacks during treatment with the selective serotonin reuptake inhibitor sertraline. A case report. Pharmacopsychiatry, 2005, Volume: 38, Issue:6 Topics: Adrenergic beta-Antagonists; Antimanic Agents; Depressive Disorder, Major; Female; Humans; Lithium; Metoprolol; Middle Aged; Migraine Disorders; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sertraline	2005
Response to SSRI-induced enuresis: a case report. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:1 Topics: Adult; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Enuresis; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline	2006
Determining the duration of antidepressant treatment: application of signal detection methodology and the need for duration adaptive designs (DAD). Biological psychiatry, 2006, Mar-15, Volume: 59, Issue:6 Topics: Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluoxetine; Follow-Up Studies; Humans; Nortriptyline; Personality Assessment; Probability; Psychometrics; Randomized Controlled Trials as Topic; Retrospective Studies; Sertraline; Signal Detection, Psychological	2006
Antidepressant therapy and C-reactive protein levels. The British journal of psychiatry : the journal of mental science, 2006, Volume: 188 Topics: Adult; Aged; C-Reactive Protein; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	2006
Treatment with selective serotonin reuptake inhibitors during pregnancy: deceleration of weight gain because of depression or drug? The American journal of psychiatry, 2006, Volume: 163, Issue:6 Topics: Adult; Depressive Disorder, Major; Feeding and Eating Disorders; Female; Humans; Nutrition Therapy; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain	2006
Serious adverse events and the modafinil augmentation study. CNS spectrums, 2006, Volume: 11, Issue:5 Topics: Benzhydryl Compounds; Central Nervous System Stimulants; Depressive Disorder, Major; Drug Synergism; Drug Therapy, Combination; Humans; Leukopenia; Modafinil; Neutropenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide	2006
Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression. JAMA, 2006, Oct-04, Volume: 296, Issue:13 Topics: Adult; Aged; Antidepressive Agents; Asian People; Depressive Disorder, Major; Female; Fluoxetine; Humans; Korea; Male; Middle Aged; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Nortriptyline; Polymorphism, Genetic; Promoter Regions, Genetic; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline	2006
Effects of antidepressant treatment on neural correlates of emotional and neutral declarative verbal memory in depression. Journal of affective disorders, 2007, Volume: 101, Issue:1-3 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Emotions; Female; Fluoxetine; Frontal Lobe; Gyrus Cinguli; Humans; Male; Mental Recall; Middle Aged; Paired-Associate Learning; Personality Inventory; Positron-Emission Tomography; Semantics; Sertraline; Venlafaxine Hydrochloride; Wechsler Scales	2007
Emotional incontinence--the other poststroke phenomenon. The Medical journal of Malaysia, 2006, Volume: 61, Issue:4 Topics: Acute Disease; Affective Symptoms; Aged; Crying; Depressive Disorder, Major; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Stroke; Time Factors	2006
Do psychiatry residents obtain informed consent for psychotherapy? Journal of the American Psychoanalytic Association, 2006,Fall, Volume: 54, Issue:4 Topics: Borderline Personality Disorder; Depressive Disorder, Major; Humans; Informed Consent; Internship and Residency; Neurotic Disorders; New York City; Prognosis; Psychoanalytic Therapy; Sertraline	2006
Antidepressant response in the elderly. Psychiatry research, 2007, Jul-30, Volume: 152, Issue:1 Topics: Adult; Age Factors; Aged; Antidepressive Agents; Anxiety Disorders; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2007
Ecchymoses as an adverse effect of fluoxetine treatment. Psychiatry research, 2007, Jul-30, Volume: 152, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Ecchymosis; Female; Fluoxetine; Follow-Up Studies; Humans; Sertraline	2007
An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials. Psychiatry research, 2007, Aug-30, Volume: 152, Issue:2-3 Topics: Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Kava; Mianserin; Mirtazapine; Paroxetine; Psychometrics; Sertraline; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Venlafaxine Hydrochloride	2007
Treatment of depression in patients with coronary artery disease. JAMA, 2007, May-02, Volume: 297, Issue:17 Topics: Aged; Citalopram; Coronary Artery Disease; Depressive Disorder, Major; Humans; Middle Aged; Psychotherapy, Brief; Selective Serotonin Reuptake Inhibitors; Sertraline	2007
Psychiatric sequelae of traumatic brain injury: a case report. The American journal of psychiatry, 2007, Volume: 164, Issue:5 Topics: Adult; Amantadine; Brain Injuries; Clinical Protocols; Cognition Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Humans; Male; Mental Disorders; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline	2007
Cognitive processes of generalized anxiety disorder in comorbid generalized anxiety disorder and major depressive disorder. Journal of anxiety disorders, 2008, Volume: 22, Issue:3 Topics: Adolescent; Adult; Antidepressive Agents; Anxiety Disorders; Attitude to Health; Cognition; Cognitive Behavioral Therapy; Comorbidity; Culture; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Sertraline; Severity of Illness Index; Surveys and Questionnaires	2008
Augmentation strategies to increase antidepressant efficacy. The Journal of clinical psychiatry, 2007, Volume: 68 Suppl 10 Topics: Algorithms; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Drug Synergism; Humans; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sertraline	2007
Reversal of trichotillomania with aripiprazole. Depression and anxiety, 2008, Volume: 25, Issue:6 Topics: Adult; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Morpholines; Piperazines; Quinolones; Reboxetine; Self Concept; Sertraline; Social Adjustment; Trichotillomania	2008
Sertraline versus venlafaxine XR in major depressive disorder. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:10 Topics: Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride	2007
Sertraline and tic: case report. Pharmacopsychiatry, 2007, Volume: 40, Issue:6 Topics: Adult; Depressive Disorder, Major; Eyelids; Female; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Stereotyped Behavior; Tics	2007
Serotonin syndrome associated with sertraline monotherapy at therapeutic doses. Progress in neuro-psychopharmacology & biological psychiatry, 2008, Apr-01, Volume: 32, Issue:3 Topics: Aged; Depressive Disorder, Major; Humans; Male; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline	2008
A comparison of antidepressant use in Nova Scotia, Canada and Australia. Pharmacoepidemiology and drug safety, 2008, Volume: 17, Issue:7 Topics: Aged; Antidepressive Agents; Australia; Canada; Databases, Factual; Depressive Disorder, Major; Female; Humans; Male; Nova Scotia; Paroxetine; Practice Patterns, Physicians'; Prevalence; Selective Serotonin Reuptake Inhibitors; Sertraline	2008
Exercise, pharmacotherapy, and depression. Psychosomatic medicine, 2008, Volume: 70, Issue:2 Topics: Antidepressive Agents; Depressive Disorder, Major; Exercise; Humans; Sertraline; Treatment Outcome	2008
Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clinical & developmental immunology, 2007, Volume: 2007 Topics: Adult; Antidepressive Agents; Chemokine CCL2; Cytokines; Depressive Disorder, Major; Enzyme-Linked Immunosorbent Assay; Female; Humans; Interleukin-12; Interleukin-2; Interleukin-4; Male; Sertraline; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha	2007
Serotonin syndrome induced by augmentation of SSRI with methylphenidate. Psychiatry and clinical neurosciences, 2008, Volume: 62, Issue:2 Topics: Central Nervous System Stimulants; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Humans; Methylphenidate; Middle Aged; Neurologic Examination; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline	2008
Trends in antidepressant use in the older population: results from the LASA-study over a period of 10 years. Journal of affective disorders, 2008, Volume: 111, Issue:2-3 Topics: Adult; Age Distribution; Age Factors; Aged; Antidepressive Agents; Citalopram; Cognition Disorders; Comorbidity; Depressive Disorder; Depressive Disorder, Major; Disability Evaluation; Drug Utilization; Geriatric Assessment; Humans; Longitudinal Studies; Middle Aged; Multivariate Analysis; Netherlands; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome	2008
Serotonin transporter gene polymorphisms and sertraline response in major depression patients. Genetic testing, 2008, Volume: 12, Issue:2 Topics: Adolescent; Adult; Antidepressive Agents; Depressive Disorder, Major; Female; Genotype; Humans; Male; Middle Aged; Minisatellite Repeats; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Treatment Outcome; Turkey	2008
Seizure associated with sertraline. The Australian and New Zealand journal of psychiatry, 1999, Volume: 33, Issue:6 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy, Tonic-Clonic; Female; Humans; Patient Admission; Sertraline	1999
Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression. Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:2 Topics: Benzothiazoles; Chronic Disease; Depressive Disorder, Major; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Middle Aged; Pramipexole; Selective Serotonin Reuptake Inhibitors; Sertraline; Thiazoles	2000
Dose of selective serotonin uptake inhibitors across pregnancy: clinical implications. Depression and anxiety, 2000, Volume: 11, Issue:2 Topics: Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2000
Simultaneous determination of human plasma levels of four selective serotonin reuptake inhibitors by high-performance liquid chromatography. Therapeutic drug monitoring, 2000, Volume: 22, Issue:3 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Fluorometry; Fluoxetine; Fluvoxamine; Humans; Linear Models; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline	2000
Depression management programs. Archives of family medicine, 2000, Volume: 9, Issue:8 Topics: Antidepressive Agents; Depressive Disorder, Major; Family Practice; Humans; Managed Care Programs; Psychiatric Status Rating Scales; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline; United States	2000
CYP2D6 inhibition in patients treated with sertraline. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:2 Topics: Adult; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder, Major; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline	1997
[Effective treatment of depressive disorder with psychotic symptoms by olanzapine combination therapy]. Deutsche medizinische Wochenschrift (1946), 2000, Dec-15, Volume: 125, Issue:50 Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychotic Disorders; Sertraline; Treatment Outcome	2000
Prefrontal changes and treatment response prediction in depression. Seminars in clinical neuropsychiatry, 2001, Volume: 6, Issue:2 Topics: Adult; Antidepressive Agents; Cyclohexanols; Depression; Depressive Disorder, Major; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Prefrontal Cortex; Sertraline; Venlafaxine Hydrochloride	2001
Forced titration as a confound in an SSRI comparator study of sertaline versus citalopram in the treatment of major depressive disorder. Biological psychiatry, 2001, Jul-01, Volume: 50, Issue:1 Topics: Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline	2001
Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biological psychiatry, 2001, Nov-01, Volume: 50, Issue:9 Topics: Adolescent; Adult; Affect; Amygdala; Antidepressive Agents; Depressive Disorder, Major; Facial Expression; Functional Laterality; Humans; Magnetic Resonance Imaging; Middle Aged; Perceptual Masking; Psychiatric Status Rating Scales; Reaction Time; Sertraline	2001
Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2001,Fall, Volume: 9, Issue:4 Topics: Aged; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder, Major; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Quality of Life; Sertraline	2001
Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients? The Journal of clinical psychiatry, 2001, Volume: 62, Issue:10 Topics: Adult; Anxiety Disorders; Bupropion; Comorbidity; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Personality Inventory; Randomized Controlled Trials as Topic; Retrospective Studies; Sertraline; Treatment Outcome	2001
Depression and panic disorder after heart transplantation--treatment with sertraline. Pharmacopsychiatry, 2002, Volume: 35, Issue:1 Topics: Antidepressive Agents; Depressive Disorder, Major; Heart Transplantation; Humans; Male; Middle Aged; Myocardial Infarction; Panic Disorder; Sertraline	2002
Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2002, Volume: 47, Issue:2 Topics: Adult; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Bupropion; Canada; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2002
Clinical outcome and tolerability of sertraline in major depression: a study with plasma levels. Progress in neuro-psychopharmacology & biological psychiatry, 2002, Volume: 26, Issue:3 Topics: Adult; Age Factors; Aged; Analysis of Variance; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Sertraline; Treatment Outcome	2002